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Riassunto 
 
L’attività di ricerca svolta durante il periodo di Dottorato ha riguardato lo studio 
dell’interazione tra il fattore di allungamento archeobatterico 1α da Sulfolobus 
solfataricus (SsEF–1α) ed alcuni ligandi eubatterici, ovvero due antibiotici, la 
tetraciclina e la pulvomicina, e un nucleotide guanilico modificato, il ppGpp. E’ 
stato scelto tale fattore di allungamento perché era già stato ampiamente 
caratterizzato, sia dal punto di vista strutturale sia riguardo le sue proprietà 
funzionali, nel laboratorio dove è stato condotto il lavoro ricerca. SsEF–1α 
presenta caratteristiche strutturali simili all’analogo eubatterico EF–Tu e 
proprietà funzionali più simili all’analogo fattore eucariotico. 
La tetraciclina e la pulvomicina sono antibiotici eubatterici che inibiscono la 
sintesi proteica. Mentre la tetraciclina impedisce il legame dell’aa–tRNA al sito 
A del ribosoma, la pulvomicina inibisce la formazione del complesso ternario tra 
il fattore di allungamento Tu (EF–Tu)‚ il GTP e l’aa–tRNA. Lo studio 
dell’interazione tra la tetraciclina o la pulvomicina ed SsEF–1α è stato effettuato 
sia in termini degli effetti prodotti dai due antibiotici sulle proprietà biochimiche 
dell’enzima sia mediante spettroscopia in fluorescenza. Riguardo gli effetti sulle 
proprietà funzionali di SsEF–1α, entrambi gli antibiotici sono in grado di inibire 
la sintesi proteica in un sistema ricostituito in vitro contenente tutti i componenti 
macromolecolari purificati da S. solfataricus. Nelle reazioni parziali catalizzate 
da SsEF–1α, la pulvomicina, ma non la tetraciclina, produce una riduzione 
dell’affinità del fattore di allungamento per l’aa–tRNA solo in the presenza del 
GTP. La tetraciclina produce un aumento della velocità di scambio GDP/GTP ed 
una lieve inibizione dell’attività GTPasica intrinseca; viceversa, in presenza di 
pulvomicina, lo scambio è circa 1,5 volte più veloce per entrambi i nucleotidi 
guanilici, e si osserva una stimolazione dell’attività GTPasica. Inoltre, mentre la 
tetraciclina produce una leggera destabilizzazione della proteina alla 
denaturazione termica, la pulvomicina esercita un effetto protettivo su SsEF–1α 
nei riguardi della denaturazione chimica. Per quanto riguarda gli studi 
spettroscopici in fluorescenza, entrambi gli antibiotici inducono una variazione 
dello spettro di fluorescenza nella regione dei residui aromatici della proteina. In 
particolare, la tetraciclina è in grado di aumentare la resa quantica della 
fluorescenza di SsEF–1α e di Ss(GM)EF–1α, una sua forma troncata costituita 
dai domini G ed M, ma non di Ss(G)EF–1α, una sua forma troncata costituita 
dal solo dominio G; tale risultato indica che il dominio M è indispensabile per 
 IV 
l’interazione con questo antibiotico. La pulvomicina, invece, esercita un 
quenching della fluorescenza al massimo di assorbimento (314 nm) con la 
comparsa di un nuovo picco a circa 360 nm per tutte le proteine analizzate, 
suggerendo che la forma intatta del fattore di allungamento è necessaria per 
l’interazione. 
Il ppGpp, chiamato anche “magic spot I”, svolge la sua azione nei batteri e nelle 
piante durante lo “Stringent Control”, ovvero in condizioni di stress cellulare e 
di mancanza di sostanze nutritive. Esso è in grado di inibire i fattori di 
allungamento della sintesi proteica in caso di carenza di amminoacidi. Ha una 
struttura simile a quella del GDP, ma presenta un gruppo difosfato addizionale 
legato all’ossigeno in posizione 3’ del ribosio. E’ stata studiata l’interazione tra 
SsEF–1α e questa molecola non solo perché tale fattore di allungamento è in 
grado di interagire con i nucleotidi guanilici, ma soprattutto perché il ppGpp è 
stato trovato legato ad SsEF–1α nella struttura cristallina di una sua forma 
ricombinante. Il ppGpp è in grado di inibire la sintesi proteica in un sistema 
ricostituito in vitro. Per quanto riguarda lo studio dell’effetto del nucleotide sulla 
formazione del complesso ternario, valutata in base alla capacità di SsEF-1α di 
proteggere l’aa-tRNA dalla sua deacilazione spontanea, i risultati mostrano che 
in presenza di ppGpp l’affinità del fattore di allungamento per l’aa–tRNA è 
intermedia se confrontata con quella per il GDP e per il GTP. Inoltre, la 
presenza del nucleotide tetrafosfato riduce l’affinità di SsEF–1α per i nucleotidi 
guanilici mediante un meccanismo di inibizione competitiva. In relazione 
all’effetto sulla GTPasi, la presenza del ppGpp provoca un aumento della Km 
senza variazione della kcat, indicando anche in questo caso un comportamento da 
inibitore competitivo. Infine, la presenza del ppGpp rende SsEF–1α più stabile 
al trattamento termico. Questi risultati indicano che il gruppo difosfato extra 
presente nel ppGpp esercita un effetto protettivo sul fattore di allungamento e 
tale stabilizzazione potrebbe essere spiegata da una migliore distribuzione delle 
cariche sulla superficie della proteina. 
In conclusione, gli studi riportati nella presente tesi possono essere utili per 
valutare le relazioni filogenetiche tra fattori di allungamento appartenenti a 
diversi domini degli organismi viventi. 
 
 V 
Summary 
 
The interaction between the archaeal elongation factor 1α from Sulfolobus 
solfataricus (SsEF–1α) and some eubacterial ligands, such as eubacterial 
antibiotics, tetracycline and pulvomycin, and the modified guanosine nucleotide 
ppGpp was investigated. SsEF–1α had already been characterised for its 
structural and functional properties in the laboratory where the research work 
was carried out. This ubiquitous protein presents structural properties more 
similar to the eubacterial counterpart and functional propertis more similar to the 
eukaryal ones. 
Tetracycline and pulvomycin are eubacterial antibiotics that inhibit protein 
synthesis. Tetracycline prevents the binding of aa–tRNA to the A site of the 
ribosome, whereas pulvomycin inhibits the formation of the ternary complex 
between the elongation factor Tu (EF–Tu), GTP and aa–tRNA. The interaction 
between SsEF–1α and these antibiotics was demonstrated either by fluorescence 
spectroscopy in the aromatic region of the spectrum of this protein or by the 
effects produced by the antibiotic on some functional properties of the 
elongation factor. The results indicated that both antibiotics were able to inhibit 
archaeal protein synthesis and that pulvomycin, but not tetracycline, was able to 
reduce the affinity of SsEF–1α for aa–tRNA in presence of GTP. Moreover, 
tetracycline produced an increase in GDP/GTP exchange rate and a slight 
inhibition of the intrinsic GTPase; vice versa, in the presence of pulvomycin, the 
exchange rate was higher for both guanosine nucleotides and a stimulation of 
GTPase activity was observed. Furthermore, the interaction between SsEF–1α 
and tetracycline caused a reduction of stability to the heat treatment, whereas 
pulvomycin exerted a protective effect on the elongation factor against chemical 
denaturation. Regarding fluorescence spectroscopy, in the presence of 
tetracycline an increase in the quantum yield in the fluorescence spectrum of 
SsEF–1α was observed. A similar behaviour was also observed for Ss(GM)EF–
1α but not for Ss(G)EF–1α, two engineered forms of the elongation factor; 
these results indicated that the M–domain is essential for the interaction with 
tetracycline. Pulvomycin, instead, exerted a strong fluorescence quenching at 
λmax which was accompanied by the appearance of a new peak at 360 nm for all 
proteins analysed, suggesting that the intact form of SsEF–1α is required for the 
interaction. 
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ppGpp, also called "magic spot I", is a molecule involved in the “Stringent 
Control” both in eubacteria and plants during amino acid starvation. It is a 
compound structurally similar to GDP, characterised by the presence of an 
additional diphosphate group, bound through a phosphoester bond to the oxygen 
in position 3’ of ribose. The interaction between SsEF–1α and this molecule 
was investigated because ppGpp was found bound to a recombinant form of the 
elongation factor, used for crystallographic studies. ppGpp was able to inhibit in 
vitro protein synthesis; the affinity of SsEF–1α for aa–tRNA in presence of the 
nucleotide tetra–phosphate resulted intermediate between that for GDP and 
GTP. Moreover, ppGpp reduced the affinity of SsEF–1α for guanosine 
nucleotides through a competitive mechanism. Regarding the effect on the 
intrisic GTPase, the presence of ppGpp caused an increase of Km with any 
variation in kcat, indicating also in this case a competitive inhibition behaviour. 
Finally, the presence of the nucleotide tetra–phosphate rendered SsEF–1α more 
stable to heat treatement. 
In conclusion, the data presented demonstrated an interaction between the 
archaeal elongation factor 1α from Sulfolobus solfataricus and some eubacterial 
ligands. These results could be used as probe to investigate phylogenetic 
relationship among living domain. 
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1. Introduction 
 
1.1 Elongation cycle in protein biosynthesis 
Protein synthesis is a process, occuring through a set of reactions, in 
which ribosomes advance along the mRNA introducing the 
appropriate aminoacyl–tRNA (aa–tRNA), giving rise to the insertion 
of the amino acid units for the synthesis of the encoded protein. The 
ribosome, therefore, can be considered a small factory in which a 
complex of protein and ribosomal RNA ensure, through various 
catalytic activities, the efficiency and effectiveness of the entire 
process. It requires the intervention of a considerable number of 
translational factors, which assist the ribosomes in the development of 
the three stages characterising the process: the initiation phase, the 
elongation cycle and termination phase. The phase certainly most 
studied is that of elongation, a cyclic process, which involves the 
binding of an amino acid residue at the carboxyl terminus of the 
neosinthesising polypeptide chain. In eubacteria three elongation 
factors, called EF–Tu, EF–Ts and EF–G, are involved. The first event 
is the formation of a ternary complex between the elongation factor 
EF–Tu, GTP and aa–tRNA (Miller et al. 1977; Forster et al. 1993), 
that binds the A site of the ribosome•mRNA complex only if there is a 
correct pairing between the mRNA codon and the anticodon of aa–
tRNA (Weijland et al. 1992). Subsequently to this interaction EF–Tu 
elicits its intrinsic GTPase activity that produces the corresponding 
GDP–bound form of the factor that dissociates from the ribosome 
(Fasano et al. 1978). The switch from the active to the inactive form is 
associated with a conformational change of the enzyme (Sprinzl 
1994). The regeneration of the active form of EF–Tu, complexed with 
GTP, is ensured by the intervention of the elongation factor Ts which 
catalyses the GDP/GTP exchange on the factor. In the second phase of 
the elongation cycle, the peptidyl–transferase activity, localised on the 
50S ribosomal subunit, allows the formation of a peptide bond 
between the amino acid bound to the aa–tRNA placed on the A site, 
and the peptidyl–tRNA located on the P site of the ribosome. In the 
last phase of the elongation cycle, the elongation factor G bound to 
GTP promotes, in the order: the translocation of peptidyl–tRNA from 
Introduction 
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the A site to the P site of the ribosome, the displacement of the 
deacylated tRNA from the P site to the E site (Rheinberger 1991) and 
the simultaneous movement of an mRNA codon. The duration of the 
complete cycle of elongation is about 100 milliseconds (25 ms for the 
interaction between EF–Tu and the ribosome, 50 ms for the formation 
of the peptide bond and 25 ms for the event of translocation). 
Although the process of biosynthesis occurs with high speed, there are 
control mechanisms that regulate the efficiency, such as the codon–
anticodon interaction and the negative cooperativity between A and E 
(exit site) sites of the ribosome (Rodnina et al. 2001). 
The molecular mechanism of the elongation cycle was also studied 
from a structural point of view. In fact, the three–dimensional 
structure of the three elongation factors EF–Tu, EF–G, EF–Ts, as well 
as that of the complexes EF–Tu•EF–Ts and EF–Tu•GTP•aa–tRNA 
has been determined. More recently the three–dimensional structure of 
the ribosome has been solved (Stark 2002). Regarding the three–
dimensional structure of EF–Tu from Escherichia coli, the presence of 
three structural domains, a GDP/GTP–binding domain (G–domain), a 
middle (M) and a C–terminal (C) domain was identified (Kjeldgaard 
et al. 1992; Song et al. 1999). 
 
1.2 Antibiotics acting on EF–Tu 
The details of the mechanism of action of Escherichia coli EF–Tu 
(EcEF–Tu) have also been elucidated taking advantage of specific 
antibiotics acting on the elongation factor. In particular, it has been 
reported that kirromycin freezes EF–Tu•GDP complex on the mRNA–
programmed ribosome by preventing the structural rearrangement of 
the factor (Parmeggiani et al. 2006); tetracycline was able to inhibit 
the binding of aa–tRNA to the A site of mRNA–programmed 
ribosome (Heffron et al. 2006). In addition, pulvomycin and 
GE2270A interfere with ternary complex formation, preventing the 
interaction between EF–Tu•GTP and aa–tRNA (Parmeggiani et al. 
2006; Heffron et al. 2000). 
 
1.2.1 Tetracycline 
Tetracycline (Figure 1) is a broad spectrum bacteriostatic antibiotic, 
that inhibits the bacterial protein synthesis (Goodman & Gilman, 
Introduction 
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Figure 1. Chemical structure of tetracycline. (A) molecular structure; (B) 
“balls and sticks structure”. Carbon atoms are indicated in green, oxygen 
atoms in red and hydrogen atoms in blue.  
 
 
1997) through the bind to the 30S subunit of the ribosome; in this 
way, it prevents the access of aa–tRNA to the A site of the mRNA–
ribosome complex. More recently, the resolution of the three–
dimensional structure of a complex formed between tetracycline and 
the EF–Tu•GDP complex (Heffron et al. 2006) reopens the question 
of the molecular target(s) of this antibiotic that probably reflects 
different modes of action and ⁄ or resistant mechanisms in different 
Introduction 
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pathogens (Heffron et al. 2006). In fact, over the years several studies 
have been reported, in which ribosomal proteins (Connamacher et al. 
1968; Maxwell et al. 1968; Williams Smith 1979) or specific sites of 
16S rRNA molecules (Moazed et al. 1987; Brodersen et al. 2000; 
Pioletti et al. 2001; Hinrichs et al. 1994; Orth et al. 1999; Nonaka et 
al. 2005) are claimed to be involved in the weak interaction between 
tetracycline and ribosome (Epe et al. 1984). Therefore, the resolution 
of the structure of a complex between tetracycline and EF–Tu, in its 
GDP–bound form (Heffron et al. 2006), revalued early reports 
focusing on the involvement of this elongation factor in the 
mechanism of action of tetracycline (Gordon 1969; Ravel et al. 1969; 
Shorey et al. 1969; Skoultchi et al. 1970; Spirin et al. 1976; Semenkov 
et al. 1982). The details of the molecular contacts between the 
antibiotic and the elongation factor pointed to a binding site entirely 
located on the G–domain of EF–Tu; however, the crystallographic 
unit contains an (EF–Tu•GDP•tetracycline)2 dimer, in which the two 
G and the two M–domains of the EF–Tu molecule formed 
intramolecular contacts. Therefore, the packaging of the complex 
might involve different portions of the proteins and it is not restricted 
to the nucleotide–binding domain of the elongation factor. 
 
1.2.2 Pulvomycin 
Pulvomycin (Figure 2), isolated from Streptoverticillium netropsis, 
inhibits protein synthesis in prokaryotes, blocking the formation of the 
ternary complex between EF–Tu, GTP and aa–tRNA. In particular, 
pulvomycin interacts with the three structural domains of EF–Tu 
through its lactone ring. The regions of EF–Tu involved in the binding 
of the antibiotic have been identified both by the discovery of some 
EF–Tu mutants, resistant to the antibiotic, and by the resolution of the 
three–dimensional structure of the complex EF–Tu•pulvomycin 
(Parmeggiani et al. 2006). The amino acid residues, interacting with 
the antibiotic, are located at the interface between the three structural 
domains of EF–Tu (Ile93, Thr94, Gln98, Glu226, Arg230, Arg233, 
His273, Thr334, Arg345 and Arg385) (Zeef et al. 1994; Boon et al. 
1995). Pulvomycin interferes with the transition of EF–Tu from its 
active to its inactive form, causing a conformational change in the  
Introduction 
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Figure 2. Chemical structure of pulvomycin. (A) molecular structure; (B) 
“balls and sticks structure”. Carbon atoms are indicated in green, oxygen 
atoms in red.  
 
 
nucleotide binding site that influences nucleotide hydrolysis (Anborgh 
et al. 1991; Langen et al. 1992). 
 
1.3 (p)ppGpp interacts with EF–Tu 
The accumulation of guanosine tetra– and penta–phosphates (ppGpp 
and pppGpp, called also magic spot I and magic spot II, respectively, 
or alarmones) occurs in most eubacteria during stringent control (SC) 
(Braeken et al. 2006 ; Magnusson et al. 2005) but not in mutant strains 
lacking SC (Cashel et al. 1996). Concerning eukaryotes, the presence 
of alarmones has been demonstrated in plants where these molecules 
accumulate in chloroplasts upon biotic and abiotic stresses (Takahashi 
et al. 2004). ppGpp, a compound structurally similar to GDP, is 
characterised by the presence of an additional diphosphate group, 
bound through a phosphoester bond to the oxygen in position 3’ of 
Introduction 
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ribose (Figure 3). Its production in eubacteria can be also induced by 
stress conditions or nutritional starvation (Cashel et al. 1996; Battesti 
 
 
 
Figure 3. Chemical structure of ppGpp. 
 
 
et al. 2006). The enzymes involved in magic spot synthesis are the 
relA gene product (p)ppGpp synthetase I and the spoT gene product 
(p)ppGpp synthetase II (Potrykus et al. 2008; Atkinson et al. 2011). 
Recently, a growing number of RelA/SpoT homologues, designated 
RSH, have been identified in plants (Mizusawa et al. 2008). 
Furthermore, the identification of such proteins in the genome of 
several sources including some archaea allowed the analysis of 
phylogenetic relationships among these proteins in the tree of life 
(Atkinson et al. 2011). In bacterial cells, (p)ppGpp plays a role as a 
negative effector of stable RNA (sRNA) levels and also in several 
other aspects to SC response, such as that of restricting translational 
errors during amino acid starvation, thus influencing translation 
accuracy through different proposed mechanisms (Cashel et al. 1996). 
One of these involves the interaction of magic spots with translation 
elongation factors EF–Tu and EF–G (Rojas et al. 1984) as well as 
with the initiation factor IF–2 (Yoshida et al. 1972; Milon et al. 2006; 
Introduction 
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Mitkevich et al. 2010). The inhibition of EF–Tu, EF–G or IF–2 
functions might be involved in the control of translation fidelity 
during protein synthesis. In fact, ppGpp would slow down the 
accuracy–determining step of the reaction, acting specifically on the 
GTPase reactions catalysed by both elongation and initiation factors. 
However, a different mechanism has also been proposed in which the 
EF–Tu•ppGpp complex, upon its interaction with ribosome, can 
reduce the rate of peptide bond formation and improves proofreading 
by increasing the proportion of near–cognate aa–tRNAs rejected by 
ribosome (Rojas et al. 1984; Dix et al. 1986). In Archaea, very little is 
known on SC and in those so far studied there is a lack of SC with the 
exception of the Euryarcheota Haloferax volcanii showing a bacterial–
like SC (Cimmino et al. 1993), and Halococcus morrhuae, showing a 
SC resembling that of eukarya (Cellini et al. 2004). In Crenarchaeota, 
the genus Sulfolobus appears to contain species that are stringent as in 
bacteria, but operated in the absence of magic spots; therefore, the 
absence of (p)ppGpp production has been proposed as an additional 
criteria to differentiate between Archaea and Bacteria (Cellini et al. 
2004). 
 
1.4 Scientific hypothesis and aim of the work 
The aim of this experimental work has been the study of the 
interaction between eubacterial ligands (tetracycline, pulvomycin and 
ppGpp) and an archaeal elongation factor 1α, used as model to 
highlight the effects of these interactors on the molecular and 
functional properties of the enzyme. In particular, for this research we 
used the elongation factor 1α isolated from the thermoacidofilic 
archaebacterium Sulfolobus solfataricus (SsEF-1α) (Figure 4), 
endowed with a great thermophilicity and resistance to heat 
denaturation (Masullo et al. 1991; Granata et al 2006, 2008). In the 
laboratory where I developed my research activity, the molecular, 
functional and structural properties of SsEF–1α have been studied in 
detail (Masullo et al. 1991, 2004; Vitagliano et al. 2001, 2004; 
Granata et al. 2006, 2008), as well as those of two its engineered 
forms, constituted respectively by G–domain and GM–domains 
(Masullo et al. 1997). These studies showed a structural similarity 
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between SsEF–1α and eubacterial elongation factors and a functional 
similarity with eukaryal ones (Masullo et al. 1997). Moreover, 
regarding the interaction between archaeal protein synthesis 
elongation factors and eubacterial antibiotics, for kirromycin and 
 
 
Figure 4. Three dimensional structure of SsEF–1α . This structure has been 
obtained using iMol (PDB code 1JNY)  
 
 
GE2270A a functional interaction have already been reported 
(Masullo et al 2002, 2002; Cantiello et al. 2004). In particular, 
kirromycin is able to enhance the intrinsic GTPase activity of some 
SsEF–1α mutants, but not that of the wild–type enzyme (Masullo et 
al. 2002, 2002; Cantiello et al. 2004); vice versa, GE2270A was found 
to increase the GDP⁄GTP exchange rate and to reduce the intrinsic 
GTPase of the archaeal elongation factor (Masullo et al. 2004). All 
these considerations prompted us an investigation about the 
interaction between SsEF–1α and other eubacterial antibiotics, such as 
tetracycline and pulvomycin. 
Furthermore, in a previous structural characterisation of SsEF–1α, a 
ppGpp molecule has been found bound to the active site of a 
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recombinant elongation factor (Vitagliano et al. 2004). This finding 
was ascribed to the ppGpp produced in E. coli (Cashel et al. 1996) in 
the heterologous expression system (Ianniciello et al. 1996). 
Therefore, the effects produced by ppGpp on the molecular and 
functional properties of SsEF–1α, have also been studied. 
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2. Materials and Methods  
 
2.1 Chemicals, buffers and enzymes 
Labelled compounds and chemicals were as already reported (Masullo 
et al. 1997). Tetracycline (Sigma–Aldrich, Milan, Italy) was prepared 
as 50 mM stock solution in water and stored at –80 °C. The antibiotic 
concentration was assessed by absorbance reading at 360 nm, using a 
molar extinction coefficient of 15800 M–1?cm–1. Pulvomycin powder 
was a kind gift of Prof. Andrea Parmeggiani (Ecole Polytechnique, 
Palaiseau, France) and it was used as 28 mM stock solution in 
absolute ethanol and stored at –80 °C. The spectral quality of the 
antibiotic was checked as reported and its concentration was 
determined using a molar absorbance coefficient of 74582 M–1?cm–1 
at 320 nm in methanol (Smith et al. 1985). ppGpp was purchased by 
TriLink BioTechnologies (USA). 
The following buffers were used: buffer A: 20 mM Tris?HCl, pH 7.8, 
50 mM KCl, 10 mM MgCl2; buffer B: 20 mM Tris?HCl, pH 7.8, 10 
mM MgCl2, 1 mM DTT, 3.6 M NaCl. 
SsEF–1α and its engineered forms were produced and purified as 
already reported (Masullo et al. 1997; Ianniciello et al. 1996; Arcari et 
al. 1999). SsRibosome, SstRNA, SsEF–2 and SsFRS were purified 
from S. solfataricus cell–free extract, as reported (Raimo et al. 1992; 
Lombardo et al. 2002). 
 
2.2 SsEF–1α  assays 
The poly(U)–directed poly(Phe) synthesis was performed as already 
described (Masullo et al. 2002). The preparation of [3H]Val–
EctRNAVal, the formation of the ternary complex between the 
elongation factor, aa–tRNA and GDP or GTP or ppGpp, and the 
protection against the spontaneous deacylation of [3H]Val–EctRNAVal 
were carried out as already reported (Raimo et al. 2000). 
The ability of SsEF–1α to bind [3H]GDP or to exchange the 
radiolabelled nucleotide for GDP, GTP or ppGpp was assayed by 
nitrocellulose filtration as described (Masullo et al. 1997). The 
apparent equilibrium dissociation constant (K'd) of the binary complex 
formed between SsEF–1α and [3H]GDP was determined by Scatchard 
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plots. K'd for GTP was derived from competitive binding experiments. 
The intrinsic NaCl–dependent GTPase activity (GTPaseNa) was 
measured in the presence of 3.6 M NaCl as reported (Masullo et al. 
1994). The kcat of GTPaseNa, the Km for [γ–32P]GTP, and the inhibition 
constants were determined by Lineweaver–Burk plots as previously 
described (Masullo et al. 1994). 
The effect of pulvomycin on the thermophilicity of the GTPaseNa was 
evaluated by determining the initial velocity of [γ–32P]GTP 
breakdown in the 45–75 °C interval; the data were then treated with 
the Arrhenius equation 
 
ln v = ln A + Ea/R ? 1/T 
 
in which v is the rate of GTP hydrolysis (s–1) at a given temperature T 
(K), A is the Arrhenius constant (s–1), Ea is the energy of activation 
(J•mol–1), and R is the gas constant (8.314 J•mol–1•K–1). By plotting ln 
v against 1/T, the Ea can be derived from the slope of the straightline 
obtained. The energetic parameters of activation ∆H*, ∆S* and ∆G* 
were calculated at a given temperature by the equations 
 
∆H* = Ea – (RT) 
 
∆S* = R ? ln(h ? NA ? A/R ? T ? e) 
 
∆G* = ∆H – T∆S 
 
where h is the Plank constant (6.624?10–34 J•s), NA is the Avogadro’s 
number (6.023?1023 molecules/mol), and e is the base of the natural 
logarithm (2.718). 
The effect of tetracycline on the heat inactivation of SsEF–1α was 
evaluated by incubating 4 µM protein in buffer A at selected 
temperatures in the 87–96 °C interval. After the heat treatment, 40–µL 
aliquots were cooled on ice for 30 min and then analysed for their 
residual [3H]GDP–binding ability or GTPaseNa as reported above. The 
data were analysed through a first–order kinetic equation, and the rate 
constants of the heat inactivation process obtained (kin) were used to 
draw an Arrhenius plot, from which the energetic parameters of 
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activation can be derived as reported above. 
The effect of pulvomycin on the chemical denaturation of SsEF–1α 
was evaluated by exposing the protein to guanidine hydrochloride 
(GuHCl, Sigma Aldrich) as already reported (Granata et al. 2006), and 
determining the residual GTPaseNa. To this aim, a stock solution of 
GuHCl (6.6 M) was prepared and mixed in different amounts with 
protein solutions to give a constant final value of the protein 
concentration (10 µM) and a variable concentration of GuHCl (0–6 
M). Each sample was incubated overnight at room temperature and 
GuHCl–induced denaturation was evaluated by assaying the residual 
GTPase activity bringing each sample to a 0.6 M constant value of 
GuHCl concentration. Under these conditions, the GTPaseNa of SsEF–
1α was not affected at all. 
 
2.3 Fluorescence measurements 
Fluorescence spectra were recorded on a computer assisted Cary 
Eclipse spectrofluorimeter (Varian Inc., Mulgrave, Australia), 
equipped with an electronic temperature controller, at a scan rate of 60 
nm⁄min using an excitation wavelength of 280 nm; excitation and 
emission slits were set to 10 nm. Blanks run in the absence of the 
protein were subtracted. Spectra recorded in the presence of 
tetracycline were obtained after further additions of a concentrated 
solution of the antibiotic, were corrected for the dilution and for the 
inner filter effect because of the absorbance of the antibiotic, using a 
molar absorption coefficient at 280 nm of 17491 M–1•cm–1 determined 
from a linear Beer–Lambert plot of absorbance versus tetracycline 
concentration. 
Spectra recorded in the presence of pulvomycin were obtained after 
further additions of a concentrated solution of the antibiotic and a 
correction for the dilution was applied. The analysis of the binding 
affinity was carried out as already reported (Johansson et al. 1998, 
2000) considering that the quenched fluorescence (Q) at respective 
maximum is a function of the maximum possible quenching (Qmax) at 
an infinite ligand concentration. In particular, the binding affinity of 
the protein–pulvomycin complex (Kd) was calculated from the 
equation 
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Q = (Qmax ? [Pulvomycin]) / (Kd + [Pulvomycin]) 
 
through a double reciprocal plot. 
Heat denaturation of SsEF–1α was studied by fluorescence melting 
curve. The excitation and emission wavelengths were 280 and 311 
nm, respectively, and the excitation and emission slits were both set to 
10 nm. Blanks run in the absence of the protein were carried out in 
parallel and subtracted. The fluorescence intensity was corrected for 
temperature quenching (Underfriend 1969), normalised between 0 and 
100 % and plotted versus the temperature. 
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3. Results 
 
3.1 Interaction between SsEF–1α  and eubacterial antibiotics 
3.1.1 Effect of tetracycline on the functional properties of SsEF–1α  
The interaction between SsEF–1α and tetracycline was studied in 
terms of the effect produced by the antibiotic on the functional 
properties of the elongation factor. The first analysis regarded the 
ability of tetracycline to inhibit protein synthesis using a reconstituted 
system containing purified macromolecular components from S. 
solfataricus. The effect of tetracycline on the kinetics of [3H]Phe 
polymerisation at 75°C, reported in Figure 5A, indicated that at 2 mM 
antibiotic, a reduction of three–fold of the rate was observed. 
 
 
Figure 5. Effect of tetracycline on the poly(U)–directed poly(Phe) synthesis 
catalysed by SsEF–1α . (A) 250 µL of the reaction mixture contained 25 mM 
Tris•HCl pH 7.5, 19 mM magnesium acetate, 10 mM NH4Cl, 10 mM 
dithiothreitol, 2.4 mM ATP, 1.6 mM GTP, 0.16 mg⁄mL poly(U), 3 mM 
spermine, 0.25 µM Ssribosome, 80 µg⁄mL SstRNA, 0.1 µM SsEF–2, 2.0 µM 
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[3H]Phe (specific activity 1268 cpm⁄pmol). The reaction was started adding 
0.5 µM final concentration of SsEF–1α in the absence (empty circles) or 
presence (filled circles) of 2 mM tetracycline and carried out at 75°C. At the 
times indicated, 50–µL aliquots were withdrawn, chilled on ice and then 
analysed for the amount of [3H]Phe incorporated. (B) Effect of different 
concentrations of tetracycline. At each antibiotic concentration, the assay 
was carried out as reported in (A). (C) The data reported in (B) were treated 
as a first–order behaviour. A0 represents the activity measured in the absence 
of the antibiotic, whereas AC is the activity at the concentration C of 
tetracycline. 
 
 
The effect of different concentration of tetracycline on poly(Phe) 
incorporation is reported in Figure 5B. The concentration of antibiotic 
leading to 50% inhibition was obtained from a first–order analysis of 
the data (Figure 5C). The value derived (1.1 mM) was identical to that 
previously measured using a cell–free reconstituted system 
(Cammarano et al. 1985), even though it was at least one order of 
magnitude higher than that required for the eubacterial process. To 
identify the partial reaction catalysed by SsEF–1α, possibly affected 
by this antibiotic, the ability of SsEF–1α to interact with aa–tRNA in 
the absence or in the presence of tetracycline was studied. As shown 
in Figure 6, the amount of ternary complex formed between 
heterologous Val–EctRNAVal, SsEF–1α and nucleotides was almost 
identical either in the absence or in the presence of tetracycline, as 
revealed by the ability of the elongation factor to protect [3H]Val–
EctRNAVal against spontaneous deacylation. In addition, the antibiotic 
did not affect the affinity for the nucleotide in ternary complex 
formation, still remaining lower for GDP (Figure 6B) than for GTP 
(Figure 6A). 
 
3.1.2 Effect of pulvomycin on the functional properties of SsEF–1α  
The effects of pulvomycin on the functional properties of the 
elongation factor was also studied. The ability of pulvomycin to 
inhibit protein synthesis was investigated; the antibiotic, at 200 µM 
concentration, reduced the poly(U)–directed poly(Phe) synthesis rate 
of about 4–fold (Figure 7A). The inhibition data obtained at different 
pulvomycin concentrations (Figure 7B), treated through a first–order 
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behaviour (Figure 7C), allowed the calculation of the antibiotic 
concentration leading to 50% inhibition (173 µM). The effect of 
pulvomycin was also studied on the partial reactions catalysed by 
SsEF–1α. Concerning ternary complex, the antibiotic was able to 
decrease the affinity of the elongation factor toward aa–tRNA only in 
the presence of GTP (Figure 8A), rendering it similar to that measured 
in the presence of GDP (Figure 8B). 
 
 
 
Figure 6. Effect of tetracycline on the formation of the ternary complex 
between SsEF–1α , [3H]ValEc–tRNAVal and GDP or GTP. The mixture (30 
µL) contained 25 mM Tris•HCl, pH 7.8, 10 mM NH4Cl, 10 mM DTT, 20 mM 
magnesium acetate and 4.6 pmol of [3H]ValEc–tRNAVal (specific 
radioactivity 1521 cpm⁄pmol) and was incubated for 1h at 0°C to allow 
ternary complex formation in the presence of the indicated amount of SsEF-
1α•GTP (A) or SsEF–1α•GDP (B), in the absence (empty circles) or in the 
presence (filled circles) of 50 µM tetracycline. The deacylation reaction was 
carried out for 1h at 50°C, and the residual [3H]ValEc–tRNAVal was 
determined as cold trichloroacetic acid insoluble material.  
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Figure 7. Effect of pulvomycin on the poly(U)–directed poly(Phe) synthesis 
catalysed by SsEF–1α . (A) Kinetics of the [3H]Phe incorporation in the 
absence (empty circles) or in the presence (filled circles) of 200 µM 
pulvomycin at 75°C. The reaction mixture (250 µl) contained 0.5 µM SsEF–
1α, 0.25 mM Ssribosome, 80 µg/ml SstRNA, 0.1 µM SsEF–2, 2.0 µM 
[3H]Phe (specific activity 1514 cpm/pmol), 25 mM Tris•HCl, pH 7.5, 19 mM 
magnesium acetate, 10 mM NH4Cl, 10 mM dithiothreitol, 2.4 mM ATP, 1.6 
mM GTP, 0.16 mg/ml poly(U) and 3 mM spermine. At the times indicated, 50 
µl aliquots were withdrawn and analysed for the amount of [3H]Phe 
incorporated. (B) Effect of different concentrations of pulvomycin. (C) The
data reported in (B) were treated as a first–order behaviour. A0 represent the 
activity measured in the absence of pulvomycin, whereas AC is the activity at 
the concentration C of the antibiotic.  
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Figure 8. Effect of pulvomycin on the formation of the ternary complex 
between SsEF–1α , [3H]ValEc–tRNAVal and GTP or GDP. The reaction 
mixture (30 µl) prepared in 25 mM Tris•HCl, pH 7.8 buffer, 10 mM NH4Cl, 
10 mM DTT, and 20 mM magnesium acetate, contained 4.6 pmol of 
[3H]ValEc–tRNAVal (specific radioactivity 1185 cpm/pmol). To allow ternary 
complex formation the mixture was incubated for 1h at 0°C in the presence of 
the indicated amount of SsEF-1α•GTP (A) or SsEF-1α•GDP (B), in the 
absence (empty circles) or in the presence (filled circles) of 20 µM 
pulvomycin. The deacylation reaction was then carried out for 1h at 50°C 
and the residual [3H]ValEc–tRNAVal was determined as cold trichloroacetic 
acid insoluble material.  
 
 
3.1.3 Effect of antibiotics on the interaction between SsEF–1α  and 
guanosine nucleotides 
The effect of the antibiotics on guanosine nucleotide exchange ability 
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of SsEF–1α was also investigated. As shown in Figure 9, the presence 
of tetracycline caused a 2.1–fold higher [3H]GDP⁄GTP exchange rate 
on SsEF–1α (Figure 9A), whereas in the case of [3H]GDP⁄GDP 
exchange, both rates resulted undistinguishable from each other 
(Figure 9B). The effect of the tetracycline on the GDP binding was 
also evaluated in terms of the equilibrium dissociation constant of the 
binary complex formed with the enzyme. The data reported in Table 1 
indicated that the antibiotic slightly reduces the affinity for both 
guanosine nucleotides, and in the case of GDP, the reduced affinity 
measured in the presence of tetracycline can be ascribed to a selective 
reduction in the association rate constant. 
 
 
 
Figure 9: Effect of tetracycline on the nucleotide exchange rate catalysed 
by SsEF–1α . The reaction mixture (300 µL) prepared in buffer A contained 
0.5 µM SsEF–1α•[3H]GDP in the absence (empty circles) or in the presence 
(filled circles) of 50 µM tetracycline. The nucleotide exchange reaction was 
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started at 60°C by adding 1 mM GDP (A) or GTP (B) final concentration. At 
the times indicated, the amount of the residual radiolabelled binary complex 
was determined on 30–µL aliquots by nitrocellulose filtration. The data were 
treated according to a first–order kinetic.  
 
In presence of pulvomycin, instead, the guanosine nucleotides 
exchange rate on the archaeal elongation factor was 1.5–fold faster for 
both GDP (Figure 10A) and GTP (Figure 10B). In addition, in the 
presence of the antibiotic, the guanosine nucleotides apparent 
equilibrium dissociation constants for GDP and GTP were slightly 
lower (Table 1) and the effect produced was more evident in the case 
of GTP. Regarding the slight increased affinity for GDP, the effect of 
pulvomycin can be ascribed to a higher increase of the association 
constant with the respect to the dissociation one. 
 
 
 
Figure 10: Effect of pulvomycin on the nucleotide exchange rate catalysed 
by SsEF–1α . The reaction mixture (250 µl) prepared in buffer A contained 
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0.5 µM SsEF–1α•[3H]GDP in the absence (empty circles) or in the presence 
(filled circles) of 20 µM pulvomycin. The nucleotide exchange reaction was 
started at 60°C by adding 1 mM GDP (A) or GTP (B) final concentration. At 
the times indicated, the amount of the residual radiolabelled binary complex 
was determined on 50–µl aliquots by nitrocellulose filtration. The data were 
treated according to a first–order kinetic.  
 
 
Table 1. Effect of tetracycline and pulvomycin on the affinity of SsEF-1α  
for guanosine nucleotides at 60°C. The Kd' and k–1 values represent the 
average of 3–4 different determinations. k+1 was calculated as k–1⁄Kd'.  
 
 K'd k-1 k+1 
SsEF-1α GDP (µM) 
GTP 
(µM–1) 
GDP 
(min–1) 
GDP 
(µM–1•min–1) 
w/o antibiotic 0.33 ± 0.09 5.35 ± 1.40 0.13 ± 0.03 0.40 
+ tetracycline 0.50 ± 0.10 9.00 ± 2.00 0.12 ± 0.04 0.24 
+ pulvomycin 0.30 ± 0.11 2.60 ± 2.00 0.19 ± 0.01 0.63 
 
 
To better evaluate the effect of the antibiotics on the interaction 
between SsEF–1α and guanosine nucleotides, we have verified 
whether tetracycline affected the intrinsic GTPase of the elongation 
factor and its truncated forms triggered by high concentration of NaCl 
(Masullo et al. 1994, 1997). The results shown in Figure 11 indicate 
that tetracycline inhibited the GTPaseNa of SsEF–1α but not that 
elicited by two its engineered forms, lacking the C–terminal 
(Ss(GM)EF–1α) or both the C– and the M–domains (Ss(G)EF–1α) 
(Masullo et al. 1997). The inhibition level observed for SsEF–1α 
depended on the antibiotic concentration (Figure 11A), even though a 
complete inhibition was not reached even in the presence of 120 µM 
antibiotic, a concentration corresponding to about 200–fold molar 
excess over that of SsEF–1α. However, the concentration of 
tetracycline for half inhibition of SsEF–1α GTPase can be calculated 
as about 322 µM (Figure 11B). The effect of the antibiotic on the 
kinetic parameters of the reaction (Table 2) indicated that tetracycline 
exerted a mixed inhibition; in fact, besides a reduced maximum 
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hydrolytic rate, also a slight reduced affinity for the nucleotide was 
observed. 
 
 
 
Figure 11. Effect of tetracycline on the intrinsic GTPase of SsEF–1α  and 
its engineered forms. (A) The GTPaseNa activity of SsEF–1α (filled 
triangles), Ss(GM)EF–1α (empty circles), Ss(G)EF–1α (filled circles) was 
determined in the presence of the indicated tetracycline concentration. The 
kinetic parameters were determined in buffer B using 0.5 µM SsEF–1α and 
1.5–30 µM [γ–32P]GTP (specific radioactivity 8582–551 cpm⁄pmol). The 
reaction was followed kinetically at 60°C and the amount of 32Pi released 
determined on 50–µL aliquots. The data were referred to the value measured 
in the absence of the antibiotic. (B) The data referring to SsEF–1α were 
linearised using a first–order behaviour equation.  
 
 
Regarding the effect of pulvomycin on GTPase activity, we observed 
an opposite behaviour. In fact, as reported in Figure 12A, increasing 
antibiotic concentration increased the rate of the intrinsic GTPase 
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Table 2. Effect of tetracycline and pulvomycin on kinetic parameters of the 
intrinsic GTPase catalysed by SsEF–1α . 
 
 Km kcat kcat/Km 
SsEF–1α  (µM)  (min–1)  (min–1•µM –1) 
w/o antibiotic 3.4 ± 1.2 0.44 ± 0.12 0.13 
+ tetracycline 4.5 ± 1.3 0.36 ± 0.14 0.08 
+ pulvomycin 2.6 ± 1.0 1.04 ± 0.20 0.40 
 
 
catalysed by SsEF–1α, reaching its maximum stimulation effect at 30 
µM. This stimulation was not observed for the truncated forms. The 
data reported for SsEF–1α up to a concentration of pulvomycin of 30 
µM followed a saturation behaviour and, through a double reciprocal 
plot (Figure 12B), the concentration of pulvomycin required for 50% 
stimulation (5.4 µM) can be derived from the X–axis intercept. The 
effect of the antibiotic on the kinetic parameters of the GTPaseNa was 
also studied. The data reported in Table 2 indicated that the increased 
catalytic efficiency, measured in the presence of 20 µM pulvomycin 
can be ascribed to an increased affinity for the substrate together with 
an higher hydrolytic rate. Furthermore, the GTPaseNa was 
competitively inhibited by GDP and GTP also in the presence of 
pulvomycin (Table 2). In particular, the inhibition power, evaluated 
through the comparison of the inhibition constants by GDP or 
GppNHp (a slowly hydrolysable GTP analog), was reduced by 4–fold 
for both nucleotides, thus confirming the observed increased affinity 
for the guanosine nucleotides in the presence of the antibiotic (not 
shown). The effect of pulvomycin on the thermophilicity of GTPaseNa 
was also analysed in the 45–75 °C temperature interval and the 
antibiotic exerted its stimulatory effect at all the tested temperatures 
(Figure 13A). The analysis of data through the Arrhenius equation, 
gave a straight–line also in the presence of the antibiotic, but with a 
different slope with respect to that obtained in its absence (Figure 
13B). From these data the energetic parameters of activation of 
GTPaseNa in absence or in presence of pulvomycin were calculated 
and reported in Table 3. The antibiotic reduced the energy of 
activation of the hydrolytic reaction without changing the free energy 
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of activation. However, a differential effect on the other 
thermodynamic parameters of activation was observed; in particular, 
pulvomycin produced a favourable variation of enthalpy of activation 
that is accompanied by an unfavourable variation of the entropy. 
 
 
Figure 12. Effect of pulvomycin on the intrinsic GTPase of SsEF–1α  and 
its engineered forms. (A) The GTPaseNa of SsEF–1α (filled circles), 
Ss(GM)EF–1α (filled squares) and Ss(G)EF–1α (filled triangles), was 
determined in the presence of the indicated pulvomycin concentration. The 
reaction mixture contained 0.5 µM SsEF–1α and 25 µM [γ–32P]GTP 
(specific activity 400–900 cpm/pmol) in 200 µL of buffer B. The reaction was 
followed kinetically at 50°C, and the amount of 32Pi released was determined 
on 40–µl aliquots. The data were reported as a percentage of the activity 
measured in the absence of the antibiotic. (B) The data referring to SsEF–1α 
up to 30 µM pulvomycin were treated by the Lineweaver–Burk equation after 
the subtraction of the GTPaseNa activity of SsEF–1α measured in the absence 
of pulvomycin (0.166 min–1).  
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Figure 13. Effect of pulvomycin on the thermophilicity of the GTPaseNa 
catalysed by SsEF–1α . (A) The rate of GTP breakdown was determined as 
reported in the Materials and Methods section at the indicated temperature, 
in the absence (empty circles) or in the presence (filled circles) of 20 µM 
pulvomycin. At each temperature, the times used for the determination were 
selected in order to give a linear relationship between the time and the 
amount of [γ–32P]GTP hydrolysed. (B) Arrhenius analysis of the data 
reported in (A).  
 
 
Table 3. Effect of pulvomycin on the energetic parameters of activation of 
the GTPaseNa catalysed by SsEF–1α . ∆H, ∆S* and ∆G* were calculated at 
60°C.  
 
 Ea ∆H* ∆S* ∆G* 
SsEF–1α (kJ·mol-1) (kJ·mol-1) (J·mol·K-1) (kJ·mol) 
– pulvomycin 86 83 – 36 95 
+ pulvomycin 53 50 – 127 92 
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3.1.4 Effect of tetracycline on the heat stability of SsEF–1α  
The interaction between tetracycline and SsEF–1α was also 
investigated through the effect exerted by the antibiotic on the heat 
inactivation kinetics of the GTPaseNa catalysed by SsEF–1α in the 87–
96 °C interval. As shown in Figure 14A, the antibiotic did not affect 
the first–order behaviour of the heat inactivation kinetic at all tested 
temperature. The analysis according to the Arrhenius equation of the 
kinetic constants of the heat inactivation process (Figure 14B) allowed 
the calculation of the energetic parameters of the activation. The data 
reported in Table 4 indicated that tetracycline increased the rate of the 
heat inactivation through a reduction of the energy of activation 
without affecting the free energy associated with the process. 
 
 
 
Figure 14. Effect of tetracycline on the heat inactivation kinetics of SsEF–
1α . (A) 4 µM SsEF–1α was incubated at 87 (empty circles), 90 (filled 
circles), 93 (empty squares) or 96°C (filled squares) in the presence of 16 
µM tetracycline, and at the indicated time intervals, aliquots were withdrawn 
and placed at 0°C. The residual GTPase activity was determined as reported 
in Materials and Methods and referred to an untreated sample kept at 0°C 
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for all the experiment of the heat treatment. The data were treated as a first–
order kinetic and reported as the natural logarithm of the residual activity. 
(B) Arrhenius analysis of the heat inactivation kinetic rate constants (kin) 
derived from the slope of the equations reported in (A).  
 
 
Table 4. Effect of tetracycline on the energetic parameters of activation of 
the inactivation process of the GTPaseNa catalysed by SsEF–1α . ∆H, ∆S* 
and ∆G* were calculated at 87°C.  
 
 Ea ∆H* ∆S* ∆G* 
SsEF–1α  (kJ·mol-1)  (kJ·mol-1)  (J·mol·K-1) (kJ·mol) 
– tetracycline 361 358 665 119 
+ tetracycline 177 174 164 115 
 
 
3.1.5 Effect of pulvomycin on chemical denaturation of SsEF–1α  
The effect of antibiotic on the resistance of SsEF–1α against 
guanidine hydrochloride denaturation was verified by measuring its 
residual GTPase activity in the presence of guanidine hydrochloride at 
increasing concentrations, in the presence or in the absence of 20 µM 
pulvomycin (Figure 15). The concentration of denaturant agent to get 
50% inactivation of the GTPaseNa was 3.0 M in the absence and 3.6 M 
in the presence of the antibiotic. These results indicated that 
pulvomycin exerted a protective action against chemical denaturation 
of SsEF–1α. 
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Figure 15. Effect of pulvomycin on the chemical denaturation of SsEF–1α . 
The residual GTPaseNa was determined, after incubation of the samples at 
indicated guanidine hydrocloride concentration, as reported in Materials 
and methods, in the absence (empty circles) or in the presence (filled circles) 
of pulvomycin.  
 
3.1.6 Effect of tetracycline on the molecular properties of SsEF–1α  
The primary structure of SsEF–1α contains 10 tyrosine residues (7 in 
the G domain, 1 in the M domain and 2 in the C domain), 18 of 
phenylalanine (11 in the G domain, 3 in the M domain and 4 in the C 
domain) and two tryptophans. In particular, the tryptophan 209 is 
contained in the catalytic domain of SsEF–1α (domain G) whereas the 
other (W334) is located in the C–terminal domain. The fluorescence 
spectrum of SsEF–1α is characterised by an emission maximum at 
314 nm (Granata et al. 2006, 2008). The addition of different 
concentrations of tetracycline caused a gradual increase in the 
quantum yield (Figure 16A) and a slight shift of the emission 
maximum to higher wavelengths (about 318 nm). These results 
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indicate that tetracycline is able to bind SsEF–1α and, probably, in the 
regions containing aromatic residues. In order to better evaluate the 
binding of the antibiotic to SsEF–1α, the effect of different 
concentration of tetracycline was also assessed on the fluorescence 
spectrum of the truncated forms of the elongation factor. 
 
 
 
Figure 16. Effect of tetracycline on fluorescence spectra of SsEF–1α  and 
its engineered forms. Spectra were recorded in buffer A in the presence of 4 
µM SsEF–1α (A), Ss(GM)EF–1α (B) or Ss(G)EF–1α (C) in the absence 
(black line) or in the presence of increasing concentration of tetracycline 
ranging between 4 (blue) and 38 µM (red) shown by different colors.  
 
 
As reported in Figure 16B, the removal of both M and C domains 
caused no variation of fluorescence maximum (314 nm); whereas a 
decrease in the quantum yield (about 50%) was observed, probably 
due to the presence of a lower number of aromatic residues. Regarding 
Ss(GM)EF–1α, the fluorescence spectrum was very similar to that of 
SsEF–1α, with an emission maximum at about 310 nm. Moreover, the 
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addition of the antibiotic, caused a gradual increase in the quantum 
yield and a slight shift of the maximum towards higher wavelengths 
(about 316 nm) (Figure 16C). These results indicated that the M 
domain was essential for the interaction between tetracycline and the 
elongation factor and that this interaction rendered the aromatic 
residues less exposed to the solvent. 
For SsEF–1α and Ss(GM)EF–1α an increase in the quantum yield at 
increasing tetracycline concentration with a saturation behaviour was 
observed (Figure 17A). In fact, using a double reciprocal plot, in 
which the reciprocal of antibiotic concentration was reported on the 
abscissa axis and the reciprocal of fluorescence variation on the 
ordinate ones, straight lines were obtained (Figure 17B). From the 
intercept on the abscissa axis, a value of antibiotic concentration to 
reach half the maximum fluorescence can be calculated; in particular, 
the value derived for SsEF–1α (229 µM, Fmax 490) was significantly 
higher than that found for Ss(GM)EF–1α (50 µM, Fmax 222) but also 
for EcEF–Tu (57 µM, Fmax 87) (not shown). These findings, besides 
indicating that eubacterial EcEF–Tu has an affinity for tetracycline 
higher than archaeal SsEF–1α, confirm that the M–domain of the 
elongation factor plays a role in the antibiotic binding. 
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Figure 17. Effect of tetracycline on the fluorescence increase. (A) The 
increase in the fluorescence intensity upon excitation at 280 nm caused by 
tetracycline was measured at 314 nm for SsEF–1α (filled triangles), 310 nm 
for Ss(GM)EF–1α (empty circles), 314 nm for Ss(G)EF–1α (filled circles). 
The concentration of each protein was 4.5 µM. (B) The data reported in (A) 
were treated as a double reciprocal plot, except that referred to Ss(G)EF–1α. 
 
 
3.1.7 Effect of pulvomycin on the molecular properties of SsEF–1α  
The effect of pulvomycin on the molecular properties was also studied 
by fluorescence spectroscopy in the aromatic region of the 
fluorescence spectrum (λexc 280 nm) of SsEF–1α and its truncated 
forms. As shown in Figure 18, pulvomycin exerted for all proteins 
investigated, a strong fluorescence quenching at λmax which was 
accompanied by the appearance of a new peak at 360 nm; this 
behaviour can be explained by a combination of both a static and a 
dynamic quenching (Lakowicz 2006), as well as by an inner filter 
effect (Parker et al. 1962) due to the absorption of pulvomycin at the 
emission region of spectrum (λmax 320 nm); therefore, all these 
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findings impaired the correction for the inner filter effect (Lakowicz 
2006). Moreover, the presence of a new peak at a higher wavelength 
could indicate a conformational modification induced by antibiotic 
involving specific aromatic residues, mainly tryptophans (Lakowicz 
2006). However, a differential effect on quenching and new peak 
appearance was exerted by pulvomycin on the different proteins 
investigated. In particular, a prevalence on the quenching effect was 
observed in the case of SsEF–1α (Figure 18A), whereas a higher 
effect on the new peak appearance was observed in the case of the 
truncated forms of the elongation factor lacking the C–terminal 
(Figure 18B) or both the C– and M– domains (Figure 18C). 
 
 
 
Figure 18. Effect of pulvomycin on the fluorescence spectra of SsEF–1α  
and its engineered forms. Spectra were recorded in buffer A in the presence 
of 4 µM SsEF–1α (A), Ss(GM)EF–1α (B) or Ss(G)EF–1α (C) in the absence 
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(black line) or in the presence of increasing concentration of pulvomycin 
ranging between 4 (blue) and 38 µM (red) shown by different colors.  
 
 
The analysis of the quenching effect allowed an evaluation of the 
binding process (Johansson et al. 1998; Lakowicz 2006) through the 
variation of the quenched fluorescence (Q) against pulvomycin 
concentration (Figure 19A). 
 
 
 
 
Figure 19. Effect of pulvomycin on the fluorescence quenching. (A) The 
fluorescence at the respective maximum was plotted against increasing 
concentration of pulvomycin for SsEF–1α (filled circles, 314 nm), 
Ss(GM)EF–1α (filled squares, 311 nm) and Ss(G)EF–1α (filled triangles, 
319 nm). The dashed line reports the effect on the fluorescence of bovine 
serum albumin (346 nm), used as a negative control for the interaction. (B) 
Double reciprocal plot of the data reported in (A).  
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In fact, the linearity of the double reciprocal plot (Figure 19B), 
allowed the extrapolation of the binding constant from the abscissa 
axis intercept. The values obtained indicated that intact SsEF–1α 
showed an affinity similar to that reported for EcEF–Tu, being the Kd 
11.6 µM and 13.9 µM, respectively. In the case of SsEF–1α, the 
lacking of C–terminal domain lowered the affinity of the elongation 
factor towards pulvomycin (Kd = 23.9 µM), whereas the truncation of 
both the C– and M–domains induced a less evident effect (Kd = 16.6 
µM). 
 
3.2 Interaction between SsEF–1α  and ppGpp 
3.2.1 Effect of ppGpp on the functional properties of SsEF–1α  
The ability of ppGpp to affect archaeal poly(U)–directed poly(Phe) 
synthesis was assessed using a purified cell–free system reconstituted 
in vitro with the required components isolated from Sulfolobus 
solfataricus (De Vendittis et al. 2002). As reported in Figure 20A, 
ppGpp exerted only a weak inhibitory effect on the rate of 
poly[3H]Phe synthesis catalysed by SsEE–1α; in fact, in the presence 
of 550 µM ppGpp, a 20% reduction of the phenylalanine 
incorporation rate was observed. From the analysis of the effect 
exerted by different concentrations of ppGpp on poly(Phe) 
incorporation (Figure 20B), the concentration leading to 50 % 
inhibition (IC50 = 2.1 mM) was calculated from a semi–logarithmic 
plot, as reported in Figure 20C. Moreover, we have also investigated 
the ability of SsEF–1α to form an heterologous ternary complex with 
aa–tRNA also in the presence of ppGpp, through the protection 
against spontaneous deacylation exerted by SsEF–1α on aa–tRNA; 
the results reported in Figure 21 showed that ppGpp induced an 
intermediate affinity of the elongation factor for aa–tRNA when 
compared with that induced by GDP or GTP. 
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Figure 20. Effect of ppGpp on the poly(U)–directed poly(Phe) synthesis 
catalysed by SsEF–1α . (A) 250 µl of the reaction mixture contained 25 mM 
Tris•HCl pH 7.5, 19 mM magnesium acetate, 10 mM NH4Cl, 10 mM 
dithiothreitol, 2.4 mM ATP, 1.6 mM GTP, 0.16 mg/ml poly(U), 3 mM 
spermine, 0.25 µM Ssribosome, 80 µg/ml SstRNA, 0.1 µM SsEF–2, 2.0 µM 
[3H]Phe (specific radioactivity 3094 cpm/pmol). The reaction was started by 
addition of 0.5 µM final concentration of SsEF–1α in the absence (empty 
circles) or in presence (filled circles) of 550 µM ppGpp and carried out at 
75°C. At the times indicated, 50–µl aliquots were withdrawn, chilled on ice 
and then analysed for the amount of [3H]Phe incorporated as hot 
trichloroacetic acid insoluble material. (B) The assay was carried out as 
reported in (A) at the indicated guanosine tetra–phosphate concentration. 
(C) The data reported in (B) were treated as a semi–logarithmic plot.  
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Figure 21. Formation of the ternary complex between SsEF–1α , 
[3H]ValEc–tRNAVal and ppGpp or GDP or GTP. The mixture (30 µl) 
contained 25 mM Tris•HCl, pH 7.8, 10 mM NH4Cl, 10 mM DTT, 20 mM 
magnesium acetate and 4.6 pmol of [3H]ValEc–tRNAVal (specific 
radioactivity 847 cpm/pmol) and was incubated for 1h at 0°C to allow 
ternary complex formation in the presence of the indicated amount of SsEF–
1α•GDP (empty squares) or SsEF–1α•ppGpp (filled circles) or SsEF–
1α•GTP (empty triangles). The deacylation reaction was carried out for 1h 
at 50°C and the residual [3H]ValEc–tRNAVal was determined as cold 
trichloroacetic acid insoluble material.  
 
 
3.2.2 Effect of ppGpp on the interaction between SsEF–1α  and 
guanosine nucleotides 
The affinity of ppGpp for the archaeal elongation factor was assessed 
by competitive binding experiments between ppGpp and [3H]GDP. As 
reported in Figure 22A, the addition of increasing concentration of the 
nucleotide tetra–phosphate reduced the amount of the SsEF–
1α•[3H]GDP complex formation, thus indicating an inhibitory 
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competitive effect. From a semi–logarithmic plot of the data (Figure 
22B), the concentration leading to 50 % inhibition (252 µM) was 
calculated. 
 
 
Figure 22. ppGpp competitively inhibited the [3H]GDP binding to SsEF–
1α . (A) The reaction mixture (50 µl), containing 20 mM Tris•HCl, pH 7.8, 50 
mM KCl, 10 mM MgCl2, 25 µM [3H]GDP (specific radioactivity 512 
cpm/pmol), 1 µM SsEF-1α and increasing concentration of ppGpp (3–1000 
µM), was incubated for 30 min at 60°C to reach the equilibrium. The amount 
of the residual SsEF–1α•[3H]GDP complex was determined on 40–µl 
aliquots by nitrocellulose filtration. (B) Semi–logarithmic plot of data 
reported in (A).  
 
 
This value allowed the derivation of the equilibrium dissociation 
constant for ppGpp which was about one order of magnitude higher 
than that previously reported for GDP and slightly lower than that for 
GTP (Table 5) (Ianniciello et al. 1996). Moreover, SsEF–1α was able 
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to exchange bound [3H]GDP for free guanosine nucleotides (Figure 
23) and the exchange rate for GDP was faster than that for GTP. 
 
 
Table 5. Effect of ppGpp on the affinity of SsEF–1α  for guanosine 
nucleotides at 60°C. The Kd' and k–1 values represent the average of 3–4 
different determinations. k+1 was calculated as k–1⁄Kd'.  
 
 K'd k-1 k+1 
SsEF–1α  (µM)  (min–1)  (µM –1•min–1) 
GDP 1.6 0.10 ± 0.03 0.063 
GTP 35 0.06 ± 0.03 0.002 
ppGpp 15.7 ± 2.8 0.08 ± 0.02 0.005 
 
 
 
 
 
Figure 23. Effect of ppGpp on the nucleotide exchange rate on SsEF–1α . 
The reaction mixture (150 µl) prepared in buffer A contained 1 µM SsEF–
1α•[3H]GDP. The nucleotide exchange reaction was started at 60°C by 
adding 333 µM GDP (empty squares) or ppGpp (filled circles) or GTP 
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(empty triangles) final concentration. At the times indicated, 30–µl aliquots 
were filtered on nitrocellulose and the radioactivity retained on the filters 
was counted. The data were treated according to a first–order kinetic. Ct 
represents the concentration of SsEF–1α•[3H]GDP at the time t, whereas C0 
is its concentration at the time 0.  
 
 
The intermediate ability of ppGpp to exchange bound [3H]GDP to 
SsEF–1α confirmed the results observed for the equilibrium 
dissociation constant (Table 5). The interaction between SsEF–1α and 
ppGpp was also studied analysing the effect of the nucleotide on the 
intrinsic GTPaseNa. The catalytic activity of SsEF–1α was sensitive to 
the presence of tetra–phosphate; the data reported in Figure 24 
indicated that in the presence of different amounts of ppGpp, the rate 
of GTP breakdown catalysed by SsEF–1α was lower (Figure 24A and 
24B). 
 
 
 
Figure 24. Effect of ppGpp on the GTPaseNa of SsEF–1α . (A) The GTPase 
activity was assayed at the times indicated, in the absence (empty circles) or 
in the presence of 50 (filled circles), 100 (filled squares), 250 (filled upright 
triangles), 500 (filled diamonds) or 750 (filled inverted triangles) µM of 
ppGpp. The reaction mixture contained 0.1–0.3 µM SsEF–1α and 50 µM [γ–
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32P]GTP (specific activity 150–300 cpm/pmol). The reaction was followed 
kinetically up to 30 min at 60°C; the amount of 32Pi released was determined 
on 50–µl aliquots. (B) The rate of GTP hydrolysis carried out as in (A) were 
plotted against ppGpp concentration as a percentage of that measured in the 
absence of the nucleotide tetra–phosphate. (C) The data reported in (B) were 
linearized using a semi–logarithmic plot.  
 
 
The data, linearised using a first–order behaviour equation (Figure 
24C), allowed the evaluation of ppGpp concentration required to get 
50 % inhibition of the intrinsic GTPaseNa of SsEF-1α (320.5 µM). In 
order to get an insight on the inhibition mechanism, the kinetic 
parameters of the GTPaseNa were determined in the presence of 
different ppGpp concentration (Figure 25). 
 
 
 
Figure 25. ppGpp competitively inhibited the GTPaseNa catalysed by SsEF–
1α . (A) The initial hydrolysis rate (v) was determined at the indicated [γ–
32P]GTP concentration in the absence (empty circles) or in the presence of 
75 (filled circles), 150 (filled squares) or 300 (filled triangles). The reaction 
mixture contained 0.1–0.3 µM SsEF–1α and 50 µM [γ-32P]GTP (specific 
activity 150–300 cpm/pmol). The reaction was followed kinetically at 60°C; 
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the amount of 32Pi released was determined on 50–µl aliquots. (B) The data 
reported in (A) were treated with the Lineweaver–Burk equation.  
 
 
The data treated according to the Lineweaver–Burk equation showed 
that ppGpp induced an increase of Km without any variation in the kcat 
values (Table 6), thus indicating that the nucleotide tetra–phosphate 
acted as a competitive inhibitor. It is relevant that the calculated Ki 
value (15.5 ± 0.3 µM) was almost identical to the value of the 
equilibrium dissociation constant, determined with the competitive 
binding experiments reported in Figure 22. 
 
 
Table 6. Effect of ppGpp on kinetic parameters of the intrinsic GTPase 
catalyzed by SsEF–1α . 
 
 Km kcat kcat/Km 
SsEF–1α  (µM)  (min–1)  (min–1•µM –1) 
w/o ppGpp 2.0 ± 0.3 0.80 ± 0.22 0.20 
+ 75 µM ppGpp 11.3 ± 1.9 0.73 ± 0.26 0.07 
+ 150 µM ppGpp 21.0 ± 2.4 0.77 ± 0.29 0.04 
+ 300 µM ppGpp 40.0 ± 6.1 0.80 ± 0.35 0.02 
 
 
3.2.3 Effect of ppGpp on the thermostability of SsEF–1α  
The effect of temperature on the stability of SsEF–1α in the presence 
of ppGpp was analised by fluorescence monitored thermal 
denaturation. As shown in Figure 26, the denaturation profile of the 
elongation factor in the presence of ppGpp was shifted towards higher 
temperatures with a denaturation midpoint (96.4 °C) about 2 °C higher 
with respect to that observed for the elongation factor bound to GDP. 
These findings indicated that the extra diphosphate group present in 
the magic spot I exerted a protective effect against SsEF–1α thermal 
denaturation. 
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Figure 26. Effect of ppGpp on the fluorescence melting profile of SsEF–
1α . The increase in fluorescence intensity was measured in buffer A at the 
indicated temperatures using 2 µM SsEF–1α•GDP, in the absence (empty 
circles) or in the presence of 20 µM ppGpp (filled circles). The temperature 
increasing rate was set to 0.2°C/min. In the 65–80°C interval (omitted in the 
figure) no fluorescence variation was observed.  
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4. Discussion/Conclusions 
In this research thesis, several aspects of the action of eubacterial 
ligands on SsEF–1α functions were investigated. The interaction 
between SsEF–1α and two eubacterial antibiotics was demonstrated 
either by fluorescence spectroscopy in the aromatic region of the 
spectrum or by the effects produced by the antibiotic on some 
functional properties of the elongation factor; in particular, 
spectroscopic data showed in the presence of tetracycline an increase 
in the quantum yield in the fluorescence spectrum of SsEF–1α. A 
similar behaviour was also observed for Ss(GM)EF–1α but not for 
Ss(G)EF–1α. Therefore, these results indicated that the M–domain is 
essential for the interaction with tetracycline.  
Regarding pulvomycin, the data obtained from fluorescence 
spectroscopy, suggested a conformational change induced by the 
antibiotic upon its interaction with SsEF–1α and confirmed those 
already reported for EcEF–Tu (Parmeggiani et al. 2006, 2006). 
However, the integrity of the archaeal elongation factor is required to 
bind the antibiotic with higher affinity. Furthermore, the appearance 
of a fluorescence band at 360 nm in the presence of pulvomycin for all 
proteins investigated, is indicative of the exposition to the aqueous 
solvent of tryptophan residues, even though a resonance energy 
transfer between close tyrosines and tryptophan(s) residues (Lakowicz 
2006) cannot be excluded. In the primary structure of SsEF–1α two 
tryptophans and ten tyrosines are present, most of them in the 
nucleotide binding domain (W209, Y84, Y122, Y161, Y166, Y180, 
Y210, Y218). Therefore, the finding that the appearance of the 360 
nm band was also evident on the truncated forms of the elongation 
factor, indicated that the main target of the solvent exposition upon 
antibiotic binding, was the region comprising Trp209 (Figure 27) to 
which the resonance energy transfer could occur from tyrosines 161, 
166 and 210, surrounding this residue. 
The effects on the functional properties of the enzyme and the results 
obtained pointed to the finding that both antibiotics were able to 
inhibit protein synthesis.  
Regarding the effects on the partial reactions, any detectable effect 
was observed on ternary complex formation in presence of 
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tetracycline. Pulvomycin, instead, reduced the ability of SsEF–1α to 
form a ternary complex only in the presence of GTP, and the affinity 
for the aa–tRNA became very similar to that measured using GDP. 
 
 
 
Figure27. Close–up of the SsEF–1α  3D structure surrounding the W209. 
Tyrosines 161, 166 and 210 are indicated in red; tryptophan 209 in yellow. 
The picture was generated using the software iMol 
(http://www.pirx.com/iMol) and the PDB code 1JNY.  
 
 
These findings indicated that, as found for EcEF–Tu, even for an 
archaeal elongation factor the impairment of the ternary complex 
formation was the target of this antibiotic action (Wolf et al. 1978). 
Furthermore, tetracycline slightly reduced the affinity of SsEF–1α for 
guanosine nucleotides. In the case of GDP, the increased equilibrium 
dissociation constant of the binary complex SsEF–1α•GDP can be 
ascribed to a greater decrease in the association rate constant than the 
dissociation one. In the case of the GDP⁄GTP exchange reaction on 
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SsEF–1α, the antibiotic has a more pronounced effect, making it 
faster and more similar to GDP⁄GDP. Pulvomycin, instead, increased 
the rate of nucleotide exchange for both GDP and GTP. 
The effects of the tetracycline on the intrinsic GTPase catalysed by the 
elongation factor in the presence of NaCl appeared limited and 
undetectable on the engineered forms of the factor. This result, in 
contrast with the data reported on the spectroscopic properties, can be 
attributed to the high concentration of NaCl (3.6 M) needed to induce 
the GTPase activity of both intact (Masullo et al. 1994) and truncated 
forms of SsEF–1α (Masullo et al. 1997; Arcari et al. 1999). However, 
the concentration of antibiotic needed to get a 50% inhibition of the 
intrinsic GTPase of SsEF–1α (322 µM) is very similar to that 
obtained from fluorescence titration and of the same order of 
magnitude than that required to inhibit to 50% the in vitro protein 
synthesis in some micropathogens (400–850 µM) but also in a cell–
free reconstituted system of S. solfataricus and S. acidocaldarius 
(Cammarano et al. 1985; Katiyar et al. 1991).  
Pulvomycin had an opposite effect on GTPaseNa catalysed by SsEF–
1α. In particular, the antibiotic was able to stimulate the intrinsic 
GTPase catalysed by the elongation factor in presence of NaCl, a 
finding that was already reported for the intrinsic GTPase of EcEF–Tu 
(Parmeggiani et al. 2006), even though in that case the stimulatory 
effect was more pronounced. However, the stimulatory effect cannot 
be detected for the catalytic activity exerted by the truncated forms of 
SsEF–1α lacking the C– or both the C– and M–domains. These results 
indicated that the integrity of the elongation factor was required to 
observe the effect, and that the C–terminal domain was essential for 
the interaction. The analysis of the energetic parameters of activation 
could give an explanation of the increased hydrolytic rate of the 
reaction, measured in the presence of pulvomycin. In fact, the reduced 
energy of activation, induced by the antibiotic, was essentially due to 
a reduced enthalpy of activation, even though an unfavourable entropy 
factor leads to an unvaried free energy of activation. 
Moreover, the interaction between SsEF–1α and tetracycline caused a 
reduction of the heat inactivation of the archaeal elongation factor, as 
demonstrated by a lower value of the energy of activation of the 
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process. The analysis of the thermodynamic parameters of the heat 
inactivation process at 87°C (Table 4) indicated that the antibiotic 
reduced both the enthalpy and the entropy of activation without 
affecting the free energy associated with the process. This finding can 
be explained by a less favourable entropic factor induced by the 
antibiotic in the attainment of the activation state of the inactivation 
process. The interaction between SsEF–1α and tetracycline was also 
analysed in terms of amino acid residues of the elongation factor 
involved, through the alignment between the primary structures of 
EcEF–Tu and SsEF–1α (Figure 28). 
 
 
 
Figure 28. Primary structure alignment between EcEF–Tu and SsEF–1α . 
The alignment was carried out using the proteomics tools available at 
http://www.expasy.ch. Residues involved in tetracycline binding in EcEF–Tu 
belonging to the G–domain are highlighted in grey. Those participating in 
the dimerisation induced by tetracycline are in white and shaded in black. 
Conserved residues are indicated by an asterisk, conservative substitutions 
by a colon and semi–conservative substitutions by a dot.  
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Among the residues identified in the catalytic domain of EcEF–Tu 
involved in the binding of the antibiotic (Heffron et al. 2006), those of 
the consensus sequences of guanosine nucleotide–binding proteins 
(Asp21, Thr25, Asp80, and Pro82, EcEF–Tu numbering) as expected 
are conserved in SsEF–1α. Regarding the other residues involved in 
the interaction with the antibiotic and belonging to this domain 
(Thr64, Ser65, Val67 and Leu178, EcEF–Tu numbering), although a 
Ser65→Thr and a Val67→Met were found as conservative 
substitutions, the other two residues were not conserved in SsEF–1α 
(Thr65→Leu and Leu178→Asp, EcEF–Tu numbering, respectively). 
Concerning the amino acid residues involved in the dimer formation 
through protein–protein interaction, those participating in the 
stabilisation of the conserved flexible region Ile220→Arg223 were 
also present in SsEF–1α; vice versa, differences were found in the 
residues belonging to the Arg262→Leu264 loop, even though some of 
the residues involved in its stabilisation were conserved (Asp216 and 
Glu259). 
The interaction between the archaeal elongation factor and 
pulvomycin was also demonstrated by the finding that the antibiotic 
rendered SsEF–1α slightly more resistant to guanidine hydrochloride 
denaturation. This finding is indicative of a more compact molecular 
organisation of the elongation factor observed in the presence of 
pulvomycin. However, a direct stabilising effect of the antibiotic on 
the protein in the complex cannot be excluded. 
The interaction between SsEF–1α and ppGpp, a molecule involved in 
the stringent control both in eubacteria and plants during amino acid 
starvation, was also demonstrated. In line with previous 
crystallographic data showing that ppGpp was found bound to SsEF–
1α in the crystalline state (Vitagliano et al. 2004), the ability of magic 
spot I to interact with the elongation factor was confirmed using 
different experimental approaches based on the competitive inhibition 
exerted by ppGpp on the GDP or GTP binding to the SsEF–1α. The 
affinity of SsEF–1α for ppGpp was intermediate between that 
obtained for GDP or GTP. The interaction of the guanosine tetra–
phosphate with the enzyme affected also both the thermostability and 
the catalytic activity of SsEF–1α. The binding of ppGpp to SsEF–1α 
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produced an increase of the temperature for half denaturation by 2°C 
when compared to GDP. This finding was somehow surprising as the 
extra diphosphate group present in the ppGpp is solvent exposed and 
does not make any short–range interaction with the protein (Figure 
29). 
 
 
 
Figure 29. 3D structure of the SsEF–1α•ppGpp complex. The model was 
generated using the coordinates of SsEF–1α reported in the Worldwide 
Protein Data Bank (PDB ID: 1SKQ). The position of the terminal phosphate 
group is indicative as it is not involved in interactions with the protein atoms 
closer than 8.0 Ä and is free to rotate.  
 
 
Therefore, the over–stabilisation of protein by ppGpp binding may be 
explained by considering that SsEF–1α shows a remarkable overall 
positive charge being its isoelectric point 9.1 (Masullo et al. 1991). 
The presence of additional negative charges in ppGpp compared to 
GDP could lead to an improved charge distribution of the surface of 
the elongation factor upon magic spot binding. Significant effects 
were also observed on the partial reactions catalysed by SsEF–1α. 
Discussion 
 51 
Indeed, ppGpp was able to inhibit the intrinsic GTPaseNa of SsEF–1α 
with a dose response behaviour as also recently reported for plant 
chloroplasts (Nomura et al. 2012). Furthermore, kinetic experiments 
indicated that the nucleotide tetra–phosphate acted as a competitive 
inhibitor. It is relevant that the inhibition constant obtained (15.5 µM) 
was almost identical to that determined for the equilibrium 
dissociation constant of SsEF–1α•ppGpp binary complex (15.7 µM) 
determined in the absence of NaCl. ppGpp was also able to inhibit 
protein synthesis in vitro, although the concentration required to get 
half–inhibition (IC50 =  2.1 mM) was significantly higher than that 
required for the eubacterial (Legault et al. 1972) and eukaryal systems 
(Nomura et al. 2012; Manzocchi et al. 1973). The explanation of the 
difference in the concentration of nucleotide to measure an effect is 
probably due to the finding that the protein synthesis assay was 
carried out in the presence of several other components, mainly 
ribosomes, EF–2 and synthetic mRNA, rendering the effect of 
guanosine tetra–phosphate less powerful. 
Apparently, the results described are in disagreement with the findings 
that in the genome of S. solfataricus the genes coding for RelA and 
SpoT have not been found, no accumulation of magic spots was found 
in cell extracts of this archaeon (Cellini et al. 2004) and a BLAST 
search of amino acid sequences of RSH family (Atkinson et al. 2011) 
towards the genome of S. solfataricus gives no significative matches 
(not shown). Although a physiological role of ppGpp in S. 
Solfataricus is yet to be demonstrated, the effects on SsEF–1α can be 
ascribed to common structural/functional features of elongation 
factors isolated from different organisms, independently on the role 
that magic spots play in different species. 
In conclusion, the data presented demonstrated an interaction between 
the archaeal elongation factor 1α from Sulfolobus solfataricus and two 
eubacterial antibiotics (tetracyline or pulvomycin), as well as with a 
nucleotide tetra–phosphate. These results could be used as probe to 
investigate phylogenetic relationship among living domain. Therefore, 
the binding of ppGpp, characterised requiring structural determinants 
similar to those for GDP, could indicate that the regulation of some 
cellular processes can be achieved without interfering with the 
Discussion 
 52 
GDP/GTP balance which is important for many other metabolic ways, 
a finding already reported in Saccharomyces cerevisiae (Iglesias-Gato 
et al. 2011). 
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Abstract Guanosine tetra-phosphate (ppGpp), also known
as ‘‘magic spot I’’, is a key molecule in the stringent control
of most eubacteria and some eukarya. Here, we show that
ppGpp affects the functional and molecular properties of
the archaeal elongation factor 1a from Sulfolobus solfa-
taricus (SsEF-1a). Indeed, ppGpp inhibited archaeal pro-
tein synthesis in vitro, even though the concentration
required to get inhibition was higher than that required for
the eubacterial and eukaryal systems. Regarding the partial
reactions catalysed by SsEF-1a the effect produced by
ppGpp on the affinity for aa-tRNA was lower than that
measured in the presence of GTP but higher than that for
GDP. Magic spot I was also able to bind SsEF-1a with an
intermediate affinity in comparison to that displayed by
GDP and GTP. Furthermore, ppGpp inhibited the intrinsic
GTPase of SsEF-1a with a competitive behaviour. Finally,
the binding of ppGpp to SsEF-1a rendered the elongation
factor more resistant to heat treatment and the analysis of
the molecular model of the complex between SsEF-1a and
ppGpp suggests that this stabilisation arises from the
charge optimisation on the surface of the protein.
Keywords Elongation factor 1a  Sulfolobus solfataricus 
Stringent control  ppGpp  Magic spot  Intrinsic GTPase
Abbreviations
SC Stringent control
Ss Sulfolobus solfataricus
Ec Escherichia coli
EF Elongation factor
GTPaseNa GTPase activity of SsEF-1a measured in the
presence of 3.6 M NaCl
ppGpp Guanosine tetra-phosphate
Introduction
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1996). Concerning eukaryotes, the presence of alarmones
has been demonstrated in plants where these molecules
accumulate in chloroplasts upon biotic and abiotic stresses
(Takahashi et al. 2004). ppGpp, a compound structurally
similar to that of GDP, is characterised by the presence of
an additional diphosphate group, bound through a phos-
phoester bond to the oxygen in position 30 of ribose. Its
production in eubacteria can be also induced by stress
conditions or nutritional starvation (Cashel et al. 1996;
Battesti and Bouveret 2006). The enzymes involved in
magic spot synthesis are the relA gene product (p)ppGpp
synthetase I and the spoT gene product (p)ppGpp synthe-
tase II (Potrykus and Cashel 2008; Atkinson et al. 2011).
The latter enzyme possess both synthetic and degrading
activity and is responsible for the production of (p)ppGpp
regardless SC and amino acid starvation, thus presumably
explaining the basal level of (p)ppGpp always present in
some bacteria (Potrykus and Cashel 2008; Atkinson et al.
2011). Recently, a growing number of RelA/SpoT homo-
logues, designated RSH, have been identified in plants
(Mizusawa et al. 2008) and their role in plant physiology/
growth was previously reported (Kasai et al. 2002; van der
Biezen et al. 2000). Furthermore, the identification of such
proteins in the genome of several sources including some
archaea allowed the analysis of phylogenetic relationships
among these proteins in the tree of life (Atkinson et al.
2011). Finally, SpoT orthologs have also been recently
identified in metazoa, and their involvement in body
growth and starvation response in Drosophila melanogas-
ter have been demonstrated (Sun et al. 2010).
In bacterial cells, (p)ppGpp plays a role as a negative
effector of stable RNA (sRNA) levels and also in several
other aspects to SC response such as that of restricting
translational errors during amino acid starvation, thus
influencing translation accuracy through different proposed
mechanisms (Cashel et al. 1996). One of these involves the
interaction of magic spots with translation elongation fac-
tors EF-Tu and EF-G (Rojas et al. 1984) as well as with the
initiation factor IF-2 (Yoshida et al. 1972; Milon et al.
2006; Mitkevich et al. 2010). The inhibition of EF-Tu,
EF-G or IF-2 functions might be involved in the control of
translation fidelity during protein synthesis. In fact, ppGpp
would slow down the accuracy-determining step of the
reaction, acting specifically on the GTPase reactions cata-
lysed by both elongation and initiation factors. However, a
different mechanism has also been proposed in which the
EF-TuppGpp complex, upon its interaction with ribosome,
can reduce the rate of peptide bond formation and improves
proofreading by increasing the proportion of near-cognate
aminoacyl-tRNAs rejected by ribosome (Rojas et al. 1984;
Dix and Thompson 1986).
In Archaea very little is known on SC and in those so far
studied there is a lack of SC with the exception of the
Euryarcheota Haloferax volcanii showing a bacterial-like
SC (Cimmino et al. 1993), and Halococcus morrhuae,
showing a SC resembling that of eukarya (Cellini et al.
2004). In Crenarchaeota, the genus Sulfolobus appears to
contain species that are stringent as in bacteria, but oper-
ated in the absence of magic spots; therefore, the absence
of (p)ppGpp production has been proposed as an additional
criteria to differentiate between Archaea and Bacteria
(Cellini et al. 2004). In a previous structural characterisa-
tion of the elongation factor 1a, an enzyme isolated from
the thermoacidophilic archaebacterium Sulfolobus solfa-
taricus (SsEF-1a) endowed with a great thermophilicity
and resistance to heat denaturation (Masullo et al. 1991;
Granata et al. 2006, 2008), we found a ppGpp molecule
bound to the active site of the recombinant protein (Vita-
gliano et al. 2004). This finding was ascribed to the ppGpp
produced in E. coli (Cashel et al. 1996) in the heterologous
expression of SsEF-1a (Ianniciello et al. 1996). In order to
evaluate and to quantify the impact of binding of ppGpp to
the properties of translational elongation factors, we here
report a functional and molecular characterisation of SsEF-
1a in the presence of the magic spot I.
Materials and methods
Chemicals, buffers and enzymes
Labelled compounds and chemicals were as already
reported (Masullo et al. 1997). ppGpp was purchased by
TriLink BioTechnologies (USA).
The following buffers were used: buffer A: 20 mM
TrisHCl, pH 7.8, 50 mM KCl, 10 mM MgCl2; buffer B:
20 mM TrisHCl, pH 7.8, 10 mM MgCl2, 1 mM DTT,
3.6 M NaCl.
SsEF-1a was produced and purified as already reported
(Ianniciello et al. 1996). SsRibosome, SstRNA, SsEF-2 and
SsFRS were purified as reported (Raimo et al. 1992;
Lombardo et al. 2002).
SsEF-1a assays
The poly(U)-directed poly(Phe) synthesis was performed at
75 C as already described (Masullo et al. 2002). The
preparation of [3H]Val-EctRNAVal, the formation of the
ternary complex between the elongation factor, aa-tRNA
and GDP or GTP or ppGpp, and the protection against the
spontaneous deacylation of [3H]Val-EctRNAVal were car-
ried out as already reported (Raimo et al. 2000).
The ability of SsEF-1a to exchange [3H]GDP for unla-
belled GDP, GTP or ppGpp, the determination of
the apparent dissociation rate constant of the SsEF-
1a[3H]GDP complex and the determination of the
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equilibrium dissociation constant of the SsEF-1appGpp
complex were assessed by the nitrocellulose filtration
method as reported (Masullo et al. 1991). Values are
indicated as the mean of at least three different experiments
with the indication of the standard error.
The GTPase activity was measured in the presence of
3.6 M NaCl (GTPaseNa) (Masullo et al. 1994). Unless
otherwise indicated the reaction mixture contained
0.1–0.3 lM SsEF-1a and 50 lM [c-32P]GTP (specific
activity 150–300 cpm/pmol). The reaction was followed
kinetically up to 30 min at 60 C; the amount of 32Pi released
was determined on 50 ll aliquots as already reported
(Masullo et al. 1994); the catalytic constant of GTPaseNa, the
affinity for [c-32P]GTP and the inhibition constants for
ppGpp of GTPaseNawere determined as reported previously
(Masullo et al. 1997).
Fluorescence measurements
Heat denaturation of SsEF-1a was studied by fluorescence
melting curve realised on a computer assisted Cary Eclipse
spectrofluorimeter (Varian) equipped with an electronic
temperature controller. The excitation and emission wave-
lengths were 280 and 311 nm, respectively, and the excitation
and emission slits were both set to 10 nm. Blanks run in the
absence of the protein were carried out in parallel and sub-
tracted. The fluorescence intensity was corrected for temper-
ature quenching (Underfriend 1969), not observed for the
blank, normalised between 0 and 100 %andplotted versus the
temperature.
Results
ppGpp inhibited the archaeal protein synthesis in vitro
The ability of ppGpp to affect archaeal poly(U)-directed
poly(Phe) synthesis was assessed using a purified cell-free
system reconstituted in vitro with the required components
isolated from Sulfolobus solfataricus (De Vendittis et al.
2002). As reported in Fig. 1a, ppGpp exerted only a weak
inhibitory effect on the rate of poly[3H]Phe synthesis cat-
alysed by SsEE-1a; in fact, in the presence of 550 lM
ppGpp, a 20 % reduction of the phenylalanine incorpora-
tion rate was observed. From the analysis of the effect
exerted by different concentrations of ppGpp on poly(Phe)
incorporation (Fig. 1b), the concentration leading to 50 %
inhibition (IC50 = 2.1 mM) was derived from a semi-log-
arithmic plot, as reported in Fig. 1c.
Moreover, we have also investigated the ability of SsEF-
1a to form an heterologous ternary complex with aa-tRNA
also in the presence of ppGpp, through the protection exerted
by the elongation factor on aa-tRNA against spontaneous
deacylation; the results reported in Fig. 2 showed that ppGpp
induced an intermediate affinity of SsEF-1a for aa-tRNA
when compared with that induced by GDP or GTP.
Fig. 1 Effect of ppGpp on the poly(U)-directed poly(Phe) synthesis
catalysed by SsEF-1a. a 250 ll of the reaction mixture contained
25 mM TrisHCl pH 7.5, 19 mM magnesium acetate, 10 mM NH4Cl,
10 mM dithiothreitol, 2.4 mM ATP, 1.6 mM GTP, 0.16 mg/ml
poly(U), 3 mM spermine, 0.25 lM Ssribosome, 80 lg/ml SstRNA,
0.1 lM SsEF-2, 2.0 lM [3H]Phe (specific radioactivity 3094 cpm/
pmol). The reaction was started by addition of 0.5 lM final
concentration of SsEF-1a in the absence (open circle) or in presence
(filled circle) of 550 lM ppGpp and carried out at 75 C. At the times
indicated, 50-ll aliquots were withdrawn, chilled on ice and then
analysed for the amount of [3H]Phe incorporated as hot trichloroacetic
acid insoluble material. b The assay was carried out in triplicate as
reported in a at the indicated guanosine tetra-phosphate concentration.
The standard error bars are reported. c The data reported in b were
treated as a semi-logarithmic plot
Fig. 2 Formation of the ternary complex between SsEF-1a, [3H]Va-
lEc-tRNAVal and ppGpp or GDP or GTP. The mixture (30 ll)
contained 25 mM TrisHCl, pH 7.8, 10 mM NH4Cl, 10 mM DTT,
20 mM magnesium acetate and 4.6 pmol of [3H]ValEc-tRNAVal
(specific radioactivity 847 cpm/pmol) and was incubated for 1 h at
0 C to allow ternary complex formation in the presence of the
indicated amount of SsEF-1aGDP (open square) or SsEF–1appGpp
(filled circle) or SsEF-1aGTP (unfilled triangle). The deacylation
reaction was carried out for 1 h at 50 C and the residual [3H]ValEc-
tRNAVal was determined as cold trichloroacetic acid insoluble
material
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ppGpp interacted with SsEF-1a
The affinity of ppGpp for the archaeal elongation factor
was measured by competitive binding experiments. SsEF-
1a binds [3H]GDP with an affinity in the micromolar range
(Ianniciello et al. 1996); as reported in Fig. 3a, the addition
of increasing concentration of the tetra-phosphate nucleo-
tide reduced the amount of the SsEF-1a[3H]GDP complex
formation, thus indicating an inhibitory competitive effect.
From a semi-logarithmic plot of the data (Fig. 2b), the
concentration leading to 50 % inhibition (252 lM) was
derived. This value allowed the calculation of the equi-
librium dissociation constant for ppGpp (15.7 ± 2.8 lM)
which was about one order of magnitude higher than that
previously reported for GDP (1.6 lM) and slightly lower
than that for GTP (35 lM) (Ianniciello et al. 1996).
Furthermore, SsEF-1a was able to exchange bound
[3H]GDP for free guanosine nucleotides (Fig. 4) and the
exchange rate for GDP (first order rate constant,
k–1 = 0.10 ± 0.03 min
-1) was faster than that for GTP
(k–1 = 0.06 ± 0.03 min
-1). The intermediate ability of
ppGpp to exchange bound [3H]GDP on SsEF-1a
(k–1 = 0.08 ± 0.02 min
-1) confirmed the results observed
for the equilibrium dissociation constant.
The interaction between SsEF-1a and ppGpp was also
studied analysing the effect of the nucleotide on the intrinsic
GTPaseNa. The catalytic activity of SsEF-1awas sensitive to
the presence of tetra-phosphate; the data reported in Fig. 5
indicated that in the presence of different concentrations of
ppGpp, the rate of GTP breakdown catalysed by SsEF-1a
was lower (Fig. 5a, b). The data, linearised using a first-order
behaviour equation (Fig. 5c), allowed the evaluation of
ppGpp concentration required to get 50 % inhibition of the
intrinsic GTPaseNa of SsEF-1a (320.5 lM).
In order to get an insight on the inhibition mechanism,
the kinetic parameters of the GTPaseNa were determined in
Fig. 3 Competitive binding of [3H]GDP and ppGpp to SsEF-1a.
a The reaction mixture (50 ll), containing 20 mM TrisHCl, pH 7.8,
50 mM KCl, 10 mM MgCl2, 25 lM [
3H]GDP (specific radioactivity
512 cpm/pmol), 1 lM SsEF-1a and increasing concentration of
ppGpp (3–1000 lM), was incubated for 30 min at 60 C to reach
the equilibrium. The amount of the residual SsEF-1a[3H]GDP
complex was determined on 40-ll aliquots by nitrocellulose filtration.
b Semi–logarithmic plot of data reported in a
Fig. 4 Guanosine nucleotides exchange rate catalysed by SsEF-1a.
The reaction mixture (150 ll) prepared in buffer A contained 1 lM
SsEF-1a[3H]GDP. The nucleotide exchange reaction was started at
60 C by adding 333 lM GDP (open square) or ppGpp (filled circle)
or GTP (unfilled triangle) final concentration. At the times indicated,
30-ll aliquots were filtered on nitrocellulose and the radioactivity
retained on the filters was counted. The data were treated according
to a first-order kinetic. Ct represents the concentration of SsEF-
1a[3H]GDP at the time t, whereas C0 is its concentration at the time 0
Fig. 5 Effect of ppGpp on the GTPaseNa of SsEF-1a. a The GTPase
activity was assayed at the times indicated, as described in ‘‘Materials
and methods’’, in the absence (open circle) or in the presence of 50
(filled circle), 100 (filled square), 250 (filled upright triangle), 500
(filled diamond) or 750 (filled inverted triangle) lM of ppGpp. b The
rate of GTP hydrolysis derived from three experiments carried out as
in a were plotted against ppGpp concentration as a percentage of that
measured in the absence of the nucleotide tetra-phosphate. Standard
error bars are indicated. c The data reported in b were linearised
using a semi-logarithmic plot
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the presence of different ppGpp concentration (Fig. 6a).
The data analysed according to the Lineweaver–Burk
equation showed that ppGpp induced an increase of Km
(from 2.0 ± 0.3 lM in the absence to 11.3 ± 1.9,
21.0 ± 2.4 and 40.0 ± 6.1 lM in the presence of 75, 150,
and 300 lM ppGpp, respectively) without any variation in
the kcat values (from 0.80 ± 0.22 min
-1 in the absence to a
mean value of 0.75 ± 0.26 min-1 in the presence of the
three ppGpp concentration), thus indicating that the
nucleotide tetra-phosphate acted as a competitive inhibitor.
It is relevant that the calculated Ki value (15.5 ± 0.3 lM)
was almost identical to the value of the equilibrium dis-
sociation constant determined with the competitive binding
experiments reported in Fig. 3.
Effect of ppGpp on the thermostability of SsEF-1a
The effect of temperature on the stability of SsEF-1a in the
presence of ppGpp was here evaluated by fluorescence-
monitored thermal denaturation. As shown in Fig. 7, the
denaturation profile of the elongation factor in the presence
of ppGpp was shifted towards higher temperatures with a
denaturation midpoint (96.4 C) about 2 C higher with
respect to that observed for the elongation factor bound to
GDP. These findings indicated that the extra diphosphate
group present in the magic spot I exerted a protective effect
against SsEF-1a thermal denaturation.
Discussion
In this work, we have demonstrated that ppGpp, a molecule
involved in the stringent control both in eubacteria and
plants during amino acid starvation, was able to interact
with the archaeal elongation factor 1a from S. solfataricus
and to influence its molecular and functional properties. A
number of experiments here reported unveiled the effects
produced by ppGpp on the molecular and functional
properties of SsEF-1a. In line with previous crystallo-
graphic data showing that ppGpp was found bound to
SsEF-1a in the crystalline state (Vitagliano et al. 2004), the
ability of magic spot I to interact with the protein was
confirmed using different experimental approaches based
on the competitive inhibition exerted by ppGpp on the
GDP or GTP binding to the elongation factor. The affinity
of SsEF-1a towards ppGpp was thoroughly intermediate
between that elicited for GDP or GTP.
The interaction of the guanosine tetra-phosphate with
the protein affected also both the thermostability and the
catalytic activity of SsEF-1a. We have previously shown
that the binding of GDP to SsEF-1a increased its thermal
stability by approximately 4 C (Granata et al. 2008). This
was not unexpected as this nucleotide makes extensive
interaction with protein residues (Vitagliano et al. 2001,
2004). The binding of ppGpp to SsEF-1a produced a fur-
ther increase of the temperature by 2 C when compared to
GDP. This finding was somehow surprising as the extra
diphosphate group present in the ppGpp is solvent exposed
and does not make any short range interaction with the
protein (Fig. 8). Therefore, the over-stabilisation of protein
by ppGpp binding may be explained by considering that
SsEF-1a shows, under the experimental conditions used in
Fig. 6 Affinity of SsEF-1a for ppGpp in GTPaseNa. a The initial
hydrolysis rate (v) was determined at the indicated [c-32P]GTP
concentration in the absence (open circle) or in the presence of 75
(filled circle), 150 (filled square) or 300 (filled triangle) lM ppGpp as
reported in ‘‘Materials and methods’’. b The data reported in a were
treated with the Lineweaver–Burk equation
Fig. 7 Effect of ppGpp on the heat denaturation profile of SsEF-
1aGDP. The increase in fluorescence intensity was measured in
buffer A at the indicated temperatures using 2 lM SsEF-1aGDP, in
the absence (open circle) or in the presence of 20 lM ppGpp (filled
circle). The temperature increasing rate was set to 0.2 C/min. In the
65–80 C interval (omitted in the figure) no fluorescence variation
was observed
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this work but also in the crystallisation experiments, a
remarkable overall positive charge being its isoelectric
point 9.1 (Masullo et al. 1991). The presence of additional
negative charges in ppGpp compared to GDP could lead to
an improved charge distribution of the surface of the pro-
tein upon magic spot binding.
Significant effects were also observed on the partial
reactions catalysed by the elongation factor. Indeed, ppGpp
was able to inhibit the intrinsic GTPaseNa of SsEF-1a with
a dose response behaviour as also recently reported for
plant chloroplasts (Nomura et al. 2012). Furthermore,
kinetic experiments indicated that the nucleotide tetra-
phosphate acted as a competitive inhibitor. It is relevant
that the inhibition constant obtained (15.5 lM) was almost
identical to that determined for the equilibrium dissociation
constant of SsEF-1appGpp binary complex (15.7 lM)
determined in the absence of NaCl. Therefore, the inter-
action between the archaeal elongation factor and ppGpp
takes place regardless of the presence of the high salt
concentration.
The guanosine nucleotide tetra-phosphate was also able
to inhibit protein synthesis in vitro, although the concen-
tration required to get half–inhibition (IC50 = 2.1 mM)
was significantly higher than that required for the eubac-
terial (Legault et al. 1972) and eukaryal systems (Nomura
et al. 2012; Manzocchi et al. 1973). Compared to the
effects caused by ppGpp on the GTPaseNa of SsEF-1a,
protein synthesis inhibition required concentration of the
magic spot one order of magnitude higher. The explanation
of the difference in the concentration of nucleotide to
measure an effect is probably due to the finding that the
protein synthesis assay was carried out in the presence of
several other components, mainly ribosomes, EF-2 and
synthetic mRNA, rendering the effect of guanosine tetra-
phosphate less powerful.
Not only do the overall results reported in this paper
confirm previous crystallographic indication about the
possibility of ppGpp to interact with SsEF-1a, but also
demonstrate that magic spot I interferes with the functional
properties of the enzyme.
Apparently, the results here described are in disagree-
ment with the findings that (a) in the genome of this
archaeon the genes coding for RelA and SpoT have not been
identified, (b) no accumulation of magic spots was found in
cell extracts of S. solfataricus (Cellini et al. 2004) and (c) a
BLAST search using amino acid sequences of RSH family
(Atkinson et al. 2011) towards the genome of S. solfa-
taricus gives no significative matches (not shown).
Although a physiological role of ppGpp in S. Solfataricus
is yet to be demonstrated, the effects here reported can be
ascribed to common structural/functional features of elon-
gation factors isolated from different organisms, indepen-
dently on the role that magic spots play in different species.
Along this line, the finding that ppGpp interacts with an
archaeal elongation factor could be exploited to shed light
on the molecular mechanisms on which the effect of magic
spots on the elongation cycle takes place.
In conclusion, the inhibitory effect exerted byppGppon the
protein synthesis, here quantified on an archaeal elongation
factor is comparable to that recently reported for guanosine
nucleotides in other sources (Nomura et al. 2012). Therefore,
the binding of ppGpp, characterised by structural require-
ments similar to those required byGDP, could indicate that the
regulation of some cellular processes can be achievedwithout
interfering with the GDP/GTP balance which is important for
many other metabolic ways as reported for Saccharomyces
cerevisiae (Iglesias-Gato et al. 2011).
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a b s t r a c t
The effect of pulvomycin on the biochemical and ﬂuorescence spectroscopic properties of the archaeal
elongation factor 1a from Sulfolobus solfataricus (SsEF-1a), the functional analog of eubacterial EF-Tu, was
investigated. The antibiotic was able to reduce in vitro the rate of protein synthesis however, the
concentration of pulvomycin leading to 50% inhibition (173 mM) was two order of magnitude higher but
one order lower than that required in eubacteria and eukarya, respectively. The effect of the antibiotic on
the partial reactions catalysed by SsEF-1a indicated that pulvomycin was able to decrease the afﬁnity of
the elongation factor toward aa-tRNA only in the presence of GTP, to an extent similar to that measured
in the presence of GDP. Moreover, the antibiotic produced an increase of the intrinsic GTPase catalysed by
SsEF-1a, but not that of its engineered forms. Finally, pulvomycin induced a variation in ﬂuorescence
spectrum of the aromatic region of the elongation factor and its truncated forms. These spectroscopic
results suggested that a conformational change of the elongation factor takes place upon interaction with
the antibiotic. This ﬁnding was conﬁrmed by the protection against chemical denaturation of SsEF-1a,
observed in the presence of pulvomycin. However, a stabilising effect of the antibiotic directly on the
protein in the complex could takes place.
 2011 Elsevier Masson SAS. All rights reserved.
1. Introduction
Archaeal elongation factor 1a from Sulfolobus solfataricus (SsEF-
1a) plays a fundamental role in the elongation cycle of protein
biosynthesis [1]. SsEF-1a is the functional homologue of the
eubacterial elongation factor Tu (EF-Tu), belongs to the class of GTP-
binding proteins and possesses an intrinsic GTPase activity revealed
in the presence of a molar concentration of NaCl (GTPaseNa) [2]. The
crystal structure of SsEF-1a/EF-Tu showed the presence of three
structural distinct domains: a N-terminal domain, containing the
nucleotide binding site (G-domain), a middle (M) and a C-terminal
(C) domain [3,4]. In its active form complexed with GTP, this EF
carries the aminoacyl-tRNA on the ribosome [5]; following
codoneanticodon recognition, GTP is hydrolysed, and the resulting
inactive form bound to GDP dissociates from the ribosome. The
switch from the active to the inactive form is associated to
a conformational change of the enzymes. The intervention of the
elongation factor Ts/1b, that catalyses the GDP/GTP exchange on
the factor, promotes the regeneration of the active form [6,7]. The
details of the mechanism of action of Escherichia coli EF-Tu (EcEF-
Tu) have also been elucidated taking advantage of speciﬁc antibi-
otics acting on the elongation factor. In particular, it has been
reported that kirromycin freezes EF-Tu$GDP complex on the
mRNA-programmed ribosome by preventing the structural rear-
rangement of the factor [8]; tetracycline was able to inhibit the
binding of aminoacyl-tRNA to the A site of mRNA-programmed
ribosome [9]. In addition, pulvomycin and GE2270A interfere
with ternary complex formation preventing the interaction
between EF-Tu$GTP and aminoacyl-tRNA [8,10]. These antibiotics
do not seem to be speciﬁc for EcEF-Tu only; in fact, kirromycin was
Abbreviations: Ss, Sulfolobus solfataricus; Ec, Escherichia coli; EF, elongation
factor; GTPaseNa, GTPase activity of SsEF-1a measured in the presence of 3.6 M
NaCl.
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able to enhance the intrinsic GTPase activity of some SsEF-1a
mutants, but not that of the wild-type enzyme [11e13]; GE2270A
was found to increase the GDP/GTP exchange rate and to reduce the
intrinsic GTPase of the archaeal elongation factor [14]. Furthermore,
fusidic acid, another eubacterial antibiotic acting on the elongation
factor G, was found to interact with its archaeal functional analogue
SsEF-2 [15]. It has to be noted that, in an in vitro reconstituted
system, none of these antibiotics, except tetracycline, were able to
inhibit protein synthesis in S. solfataricus [16].
All these ﬁndings induced us to investigate the effect of
eubacterial antibiotic pulvomycin on the molecular and functional
properties of SsEF-1a. The results obtained either by ﬂuorescence
spectroscopic analysis or through the effect produced by the anti-
biotic on the elongation factor showed that pulvomycin was able to
interact with the SsEF-1a.
2. Materials and methods
2.1. Chemicals, buffers and enzymes
Labelled compounds and chemicals were as already reported
[17]. Pulvomycin powder was a gift from Prof. Andrea Parmeggiani
and it was used as 28 mM stock solution in absolute ethanol and
stored at 80 C. The spectral quality of the antibiotic was checked
as reported [18] and its concentration was determined using
a molar absorbance coefﬁcient of 74 582 M1 cm1 at 320 nm in
methanol. The following buffers were used: Buffer A: 20 mM
Tris$HCl, pH 7.8, 50 mM KCl, 10 mM MgCl2; buffer B: 20 mM
Tris$HCl, pH 7.8, 10 mM MgCl2, 1 mM DTT, 3.6 M NaCl.
SsEF-1a and its engineered or chimaeric forms were produced
and puriﬁed as already reported [17,19,20]. SsRibosome, SstRNA,
SsEF-2 and SsFRS were puriﬁed as reported [21,22].
2.2. SsEF-1a assays
The preparation of [3H]Val-EctRNAVal, the formation of the
ternary complex SsEF-1a$GTP$[3H]Val-EctRNAVal, the protection
against spontaneous deacylation of [3H]Val-EctRNAVal and
poly(U)-directed poly([3H]Phe) synthesis were carried out as
already described [5,14,21].
The ability of SsEF-1a to bind [3H]GDP or to exchange the
radiolabelled nucleotide for GDP or GTP was assayed by nitrocel-
lulose ﬁltration as described [17]. Following the titration of 1.0 mM
SsEF-1a with 0.4e4 mM [3H]GDP (speciﬁc radioactivity 3398 cpm/
pmol), the apparent equilibrium dissociation constant (Kd
0) of the
binary complex formed between SsEF-1a and [3H]GDP was deter-
mined using Scatchard plots. Kd
0 for GTP was derived through
competitive binding experiments [17] inwhich 0.5 mM SsEF-1awas
incubated in the presence of 10 mM [3H]GDP (speciﬁc radioactivity
800 cpm/pmol) and different concentrations (40e300 mM) of GTP.
The intrinsic NaCl-dependent GTPase activity (GTPaseNa) was
measured in the presence of 3.6 M NaCl as reported [2]. The reac-
tionmixture contained 0.5 mMpuriﬁed elongation factor and 25 mM
[g-32P]GTP (speciﬁc activity 400e900 cpm/pmol) in 200 mL of
buffer B. The reaction was followed kinetically at 50 C, and the
amount of 32Pi released was determined on 40 ml aliquots. The kcat
of GTPaseNa, the Km for [g-
32P]GTP, and the inhibition constants
were determined by LineweavereBurk plots as reported [2].
The effect of pulvomycin on the thermophilicity of the GTPaseNa
was evaluated by determining the initial velocity of [g-32P]GTP
breakdown in the 45e75 C interval [7]; the data were then treated
with the Arrhenius equation
lnv ¼ lnAþ Ea=R$1=T
in which v is the rate of GTP hydrolysis (s1) at a given temperature
T (K), A is the Arrhenius constant (s1), Ea is the energy of activation
(J mol1), and R is the gas constant (8.314 J mol1 K1). By plotting
ln v against 1/T, the Ea can be derived from the slope of the straight-
line obtained. The energetic parameters of activation ∆H*, ∆S* and
∆G* were calculated at a given temperature by the equations
DH	 ¼ EaðR$TÞ DS
	 ¼ R$lnðh$NA$A=R$T$eÞ DG
	 ¼ DH	TDS	
where h is the Plank constant (6.624 
 10e34 J s), NA is the Avoga-
dro’s number (6.023 
 1023 molecules/mol), and e is the base of the
natural logarithm (2.718).
The effect of pulvomycin on the chemical denaturation of SsEF-
1a was evaluated by exposing the protein to guanidine hydro-
chloride (GuHCl, SigmaeAldrich) as already reported [23], deter-
mining the residual GTPaseNa. To this aim, a stock solution of GuHCl
(6.6 M) was prepared and mixed in different amounts with protein
solutions to give a constant ﬁnal value of the protein concentration
(10 mM) and a variable concentration of GuHCl (0e6 M). Each
sample was incubated overnight at room temperature and GuHCl-
induced denaturation was evaluated by assaying the residual
GTPase activity bringing each sample to a 0.6 M constant value of
GuHCl concentration. Under these conditions, the GTPaseNa of SsEF-
1a was not affected at all.
2.3. Fluorescence measurements
Fluorescence spectra were recorded at 25 C on a computer
assisted Cary Eclipse spectroﬂuorimeter (Varian) at a scan rate of
60 nm/min using an excitation wavelength of 280 nm; excitation
and emission slits were set to 10 nm. Spectra recorded in the
presence of pulvomycin were obtained after further additions of
a concentrated solution of the antibiotic and a correction for the
dilution was applied. Blanks run in the absence of the protein were
subtracted. The analysis of the binding afﬁnity was carried out as
already reported [24,25] considering that the quenched ﬂuores-
cence (Q) at respective maximum is a function of the maximum
possible quenching (Qmax) at an inﬁnite ligand concentration. In
particular, the binding afﬁnity of the protein$pulvomycin complex
(Kd) was calculated from the equation
Q ¼ ðQmax$½PulvomycinÞ=ðKd þ ½PulvomycinÞ
through a double reciprocal plot.
3. Results
3.1. Effect of pulvomycin on the functional properties of SsEF-1a
The interaction between SsEF-1a and pulvomycin was studied
analysing the effect produced by the antibiotic on the functional
properties of the elongation factor.
In a ﬁrst approach, the ability of pulvomycin to inhibit protein
synthesis in a reconstituted system containing puriﬁed macromo-
lecular components from S. solfataricus was investigated; the
antibiotic, at 200 mM concentration, reduced the poly(U)-directed
poly(Phe) synthesis rate of about 4-fold (Fig. 1A). The inhibition
data obtained at different pulvomycin concentrations (Fig. 1B),
treated through a ﬁrst-order analysis (Fig. 1C), allowed the
extrapolation of the concentration of antibiotic leading to 50%
inhibition (173 mM).
The effect of the antibiotic was also studied on the partial
reactions catalysed by SsEF-1a. Concerning ternary complex
formation between Val-EctRNAVal, SsEF-1a and guanosine nucleo-
tides, evaluated through the ability of the elongation factor to
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protect [3H]Val-EctRNAVal against spontaneous deacylation [5],
pulvomycin was able to decrease the afﬁnity of the elongation
factor toward aa-tRNA only in the presence of GTP (Fig. 2A), to an
extent similar to that measured in the presence of GDP (Fig. 2B). 3.2. Effect of pulvomycin on the interaction between SsEF-1a
and guanosine nucleotides
The effect of pulvomycin on the interaction between the elon-
gation factor and guanosine nucleotides was assessed on both the
exchange rate and afﬁnity. In presence of pulvomycin, the guano-
sine nucleotides exchange rate on the archaeal elongation factor
was 1.5-fold faster for both GDP (Fig. 3A) and GTP (Fig. 3B). In
addition, in the presence of the antibiotic, the guanosine nucleo-
tides apparent equilibrium dissociation constants for GDP and GTP
were slightly lower (Table 1) and the effect produced was more
evident in the case of GTP. Regarding the slight increased afﬁnity for
GDP, the effect of pulvomycin can be ascribed to a higher increase of
the association constant with the respect to the dissociation one.
The interaction between pulvomycin and SsEF-1a, was also
studied by its effect on the GTPaseNa. As reported in Fig. 4A,
increasing pulvomycin concentration increased the rate of the
intrinsic GTPase catalysed by SsEF-1a, reaching its maximum
stimulation effect at 30 mM. This stimulation was not observed for
two truncated forms of the archaeal elongation factor lacking the C-
terminal (Ss(GM)EF-1a) or the C- and the M-domains (Ss(G)EF-1a)
[17], as well as for an engineered elongation factor constituted by
Fig. 2. Effect of pulvomycin on the formation of the ternary complex between SsEF-1a,
[3H]ValEc-tRNAVal and GTP or GDP. The reaction mixture (30 ml) prepared in 25 mM
Tris$HCl, pH 7.8 buffer, 10 mM NH4Cl, 10 mM DTT, and 20 mM magnesium acetate,
contained 4.6 pmol of [3H]ValEc-tRNAVal (speciﬁc activity 1185 cpm/pmol). To allow
ternary complex formation the mixture was incubated for 1 h at 0 C in the presence of
the indicated amount of SsEF-1a$GTP (A) or SsEF-1a$GDP (B), in the absence (open
symbols) or in the presence (ﬁlled symbols) of 20 mM pulvomycin. The deacylation
reaction was then carried out for 1 h at 50 C and the residual [3H]ValEc-tRNAVal was
determined as cold trichloroacetic acid insoluble material.
Fig. 3. Effect of pulvomycin on the guanosine nucleotide exchange on the SsEF-1a$[3H]
GDP complex. The reaction mixture (250 ml) prepared in buffer A contained 0.5 mM
SsEF-1a$[3H]GDP in the absence (empty symbols) or in the presence (ﬁlled symbols) of
20 mM pulvomycin. The nucleotide exchange reaction was started at 60 C by adding
1 mM GDP (A) or GTP (B) ﬁnal concentration. At the times indicated, the amount of the
residual radiolabelled binary complex was determined on 50 ml aliquots by nitrocel-
lulose ﬁltration. The data were treated according to a ﬁrst-order kinetics.
Table 1
Effect of pulvomycin on the afﬁnity of SsEF-1a for guanosine nucleotides at 60 C.
SsEF-1a Kd
0 k1 kþ1
GDP
(mM)
GTP
(mM)
GDP
(min1)
GDP
(mM1 min1)
 pulvomycin 0.35  0.10 4.7  1.5 0.13  0.02 0.37
þ pulvomycin 0.30  0.11 2.6  2.0 0.19  0.01 0.63
The Kd
0 and k1 values represent the average of 3e4 different determinations.
kþ1 was calculated as k1/Kd
0 .
Fig. 1. Effect of pulvomycin on the poly(U)-directed poly(Phe) synthesis at 75 C.
A Kinetics of the [3H]Phe incorporation in the absence (open symbol) or in the pres-
ence (ﬁlled symbol) of 200 mM pulvomycin. The reaction mixture (250 ml) contained
0.5 mM SsEF-1a, 0.25 mM Ssribosome, 80 mg/ml SstRNA, 0.1 mM SsEF-2, 2.0 mM [3H]Phe
(speciﬁc activity 1514 cpm/pmol) in 25 mM Tris$HCl, pH 7.5 buffer supplemented with
19 mM magnesium acetate, 10 mM NH4Cl, 10 mM dithiothreitol, 2.4 mM ATP, 1.6 mM
GTP, 0.16 mg/ml poly(U) and 3 mM spermine. At the times indicated, 50 ml aliquots
were withdrawn and analysed for the amount of [3H]Phe incorporated. B Effect of
different concentrations of pulvomycin. C The data reported in Bwere treated as a ﬁrst-
order behaviour. A0 represent the activity measured in the absence of pulvomycin,
whereas AC is the activity at the concentration C of the antibiotic.
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the G-domain of SsEF-1 and the M- and C- domains of EcEF-Tu [20].
The data referring to SsEF-1a up to a concentration of pulvomycin
of 30 mM followed a saturation behaviour and, through a double
reciprocal plot (Fig. 4B), the concentration of pulvomycin required
for 50% stimulation (5.4 mM) can be derived from the X-axis inter-
cept. The effect of the antibiotic on the kinetic parameters of the
GTPaseNa was also investigated. The data reported in Table 2 indi-
cated that the increased catalytic efﬁciency, measured in the
presence of 20 mM pulvomycin can be ascribed to an increased
afﬁnity for the substrate together with an higher hydrolytic rate.
Furthermore, the GTPaseNawas competitively inhibited by GDP and
the slowly hydrolysable GTP analog GppNHp also in the presence of
pulvomycin. In particular, the inhibition power, evaluated through
the comparison of the inhibition constants (Table 2), was reduced
by 4-fold for both nucleotides, thus conﬁrming the observed
increased afﬁnity for the guanosine nucleotides in the presence of
the antibiotic.
The effect of pulvomycin on the thermophilicity of GTPaseNawas
also analysed in the 45e75 C temperature interval and the anti-
biotic exerted its stimulatory function at all the tested temperatures
(Fig. 5A). The analysis of data through the Arrhenius equation, gave
a straight-line also in the presence of the antibiotic, but with
a different slope with respect to that obtained in its absence
(Fig. 5B). From these data the energetic parameters of activation of
GTPaseNa in absence or in presence of pulvomycin were calculated
and reported in Table 3. The antibiotic reduced the energy of
activation of the hydrolytic reaction without changing the free
energy of activation. However, a differential effect on the other
thermodynamic parameters of activation was observed; in partic-
ular, pulvomycin produced a favourable variation of enthalpy of
activation that is accompanied by an unfavourable variation of the
entropy.
3.3. Effect of pulvomycin on chemical denaturation of SsEF-1a
The effect of antibiotic on the resistance of SsEF-1a against
guanidine hydrochloride denaturation was investigated by
measuring its residual GTPase activity in the presence of guanidine
hydrochloride at increasing concentrations, in the presence or in
the absence of 20 mM pulvomycin (Fig. 6). The concentration of
denaturant agent to get 50% inactivation of the GTPaseNawas 3.0 M
in the absence and 3.6 M in the presence of the antibiotic. These
results indicated that pulvomycin exerted a protective action
against chemical denaturation of SsEF-1a.
3.4. Effects of pulvomycin on ﬂuorescence spectra
The effect of pulvomycin on the molecular properties was also
studied by ﬂuorescence spectroscopy in the aromatic region of the
ﬂuorescence spectrum (lexc 280 nm) of SsEF-1a and its truncated
forms and compared to that observed for EcEF-Tu. As shown in
Fig. 7, pulvomycin exerted for all proteins investigated, a strong
Fig. 4. Effect of pulvomycin on the intrinsic GTPase of SsEF-1a and its engineered
forms. A The GTPaseNa of SsEF-1a (C), Ss(GM)EF-1a (-), Ss(G)EF-1a (:), and the
archaeal/eubacterial chimaeric elongation factor (A) was determined in the presence
of the indicated pulvomycin concentration, as described in Materials and methods. The
data were reported as a percentage of the activity measured in the absence of the
antibiotic. B The data referring to SsEF-1a up to 30 mM pulvomycin were treated by the
LineweavereBurk equation after the subtraction of the GTPaseNa activity of SsEF-1a
measured in the absence of pulvomycin (0.166 min1).
Table 2
Effect of pulvomycin on the kinetic parameters of the GTPaseNa catalysed by SsEF-1a at 50 C.
Km (mM) kcat (min
1) kcat/Km
(min1 mM1)
Ki (GDP) (mM) Ki (GppNHp) (mM)
 pulvomycin 4.36  1.8 0.18  0.04 0.04 0.12  0.04 0.23  0.08
þ pulvomycin 2.61  1.0 0.47  0.14 0.18 0.47  0.10 0.93  0.15
The Km and kcat values represent the average of 3e4 different determinations.
Fig. 5. Effect of pulvomycin on the thermophilicity of the GTPaseNa catalysed by SsEF-
1a. A The rate of GTP breakdownwas determined as reported in the Methods section at
the indicated temperature, in the absence (empty symbols) or in the presence (ﬁlled
symbols) of 20 mM pulvomycin. At each temperature, the times used for the deter-
mination were selected in order to give a linear relationship between the time and the
amount of [g-32P]GTP hydrolysed. B Arrhenius analysis of the data reported in A.
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ﬂuorescence quenching at lmax which was accompanied by the
appearance of a new peak at 360 nm; this behaviour can be
explained by a combination of both a static and a dynamic
quenching [26], as well as by an inner ﬁlter effect [27] due to the
absorption of pulvomycin at the emission region of spectrum (lmax
320 nm); therefore, these ﬁndings impaired the correction for the
inner ﬁlter effect [26]. Moreover, the presence of a new peak at
a higher wavelength could indicate a conformational modiﬁcation
induced by antibiotic involving speciﬁc aromatic residues, mainly
tryptophans [26]. However, a differential effect on quenching and
new peak appearance was exerted by pulvomycin on the different
proteins analysed. In particular, a prevalence on the quenching
effect was observed in the case of SsEF-1a (Fig. 7A), whereas
a higher effect on the new peak appearance was observed in the
case of the truncated forms of the elongation factor lacking the C-
terminal (Fig. 7B) or both the C- and M- domains (Fig. 7C), but also
for EcEF-Tu (Fig. 7D). These results, although to a lesser extent, were
also observed using an excitation wavelength of 295 nm (not
shown).
The analysis of the quenching effect allowed an evaluation of the
binding process [24,25] through the variation of the quenched
ﬂuorescence (Q) against pulvomycin concentration (Fig. 8A). In fact,
the linearity of the double reciprocal plot (Fig. 8B), allowed the
extrapolation of the binding constant from the abscissa axis inter-
cept. The values obtained indicated that intact SsEF-1a and EcEF-Tu
showed a similar afﬁnity for the drug being the Kd 11.6 mM and
13.9 mM, respectively. In the case of SsEF-1a the lacking of C-
terminal domain lowered the afﬁnity of the elongation factor
towards pulvomycin (Kd¼ 23.9 mM), whereas the truncation of both
the C- and M-domains induced a less evident effect (Kd ¼ 16.6 mM).
4. Discussion
In this work, several aspects of the action of pulvomycin, on the
molecular and functional properties of SsEF-1a were investigated.
The results obtained indicated that this eubacterial antibiotic, iso-
lated from Streptoverticillium netropsis [18], was able to interact
with the archaeal elongation factor. It was previously reported that
pulvomycin at 1 mM ﬁnal concentration was not able to inhibit
Table 3
Effect of pulvomycin on the energetic parameters of activation of GTPaseNa of SsEF-
1a.
Ea
(kJ mol1)
∆Ha
(kJ mol1)
∆Sa
(J mol K1)
∆Ga
(kJ mol)
 pulvomycin 86 83 36 95
þ pulvomycin 53 50 127 92
a Calculated at 60 C.
Fig. 6. Effect of pulvomycin on the chemical denaturation of SsEF-1a. The residual
GTPaseNa was determined, after incubation of the samples at indicated guanidine
hydrocloride concentration, as reported in Materials and methods, in the absence
(empty symbols) or in the presence (ﬁlled symbols) of pulvomycin.
Fig. 7. Effect of pulvomycin on ﬂuorescence spectra of SsEF-1a and its engineered
forms. Spectra were recorded in buffer A in the presence of 4 mM SsEF-1a (A), Ss(GM)
EF-1a (B), Ss(G)EF-1a (C) or EcEF-Tu (D) in the absence (black line) or in the presence of
increasing concentration of pulvomycin ranging between 4 (blue) and 38 mM (red)
shown by different colors. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
Fig. 8. Quenching analysis of the interaction between pulvomycin and SsEF-1a or its
engineered forms. A The ﬂuorescence at the respective maximum was plotted against
increasing concentration of pulvomycin for SsEF-1a (C, 314 nm), Ss(GM)EF-1a (-,
311 nm), Ss(G)EF-1a (:, 319 nm), and EcEF-Tu (A, 310 nm). The dashed line reports
the effect on the ﬂuorescence of bovine serum albumin (346 nm), used as a negative
control for the interaction. B Double reciprocal plot of the data reported in A.
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protein synthesis in a reconstituted cell-free system from S. sol-
fataricus [16]. The availability of puriﬁed macromolecular compo-
nents of S. solfataricus required for an in vitro protein synthesis
assay showed that pulvomycin was able to inhibit poly(U)-directed
poly(Phe) synthesis; however, the concentration of antibiotic
required to get 50% inhibition (173 mM) was at least two order of
magnitude higher than that measurable for both gram-negative
and gram-positive eubacterium [28,29], and some methanogenic
archaea [30], but at least one order of magnitude lower than that
required for Saccharomyces cerevisiae [30] or other eukaryotic cells
[31]. These ﬁndings prompted us an investigation on the effect
exerted by pulvomycin on the partial reactions catalysed by SsEF-
1a. The results obtained indicated that the antibiotic affected the
different functional properties of the elongation factor but at
concentrations signiﬁcantly lower than that required for the inhi-
bition of protein synthesis. This difference can be explained by the
ﬁnding that the protein synthesis assay was carried out in the
presence of several components, mainly ribosomes, EF-2 and
synthetic mRNA, rendering the effect of the antibiotic less power-
ful. However, no effect was exerted by pulvomycin on the intrinsic
(Supplementary material Fig. S1) and ribosome-dependent
(Supplementary material Fig. S2) GTPase catalysed by SsEF-2.
Therefore, a speciﬁc effect of pulvomycin on both ribosome and
EF-2 can be excluded. On the other hand, this behaviour was also
reported for the effects exerted by two other eubacterial antibiotics
acting on the partial reactions catalysed by SsEF-1a [14,32].
Regarding the effects on the partial reactions, the presence of the
antibiotic reduced the ability of SsEF-1a to form a ternary complex
only in the presence of GTP, and the afﬁnity for the aa-tRNA became
very similar to that measured using GDP. These ﬁndings indicated
that, as found for EcEF-Tu, even for an archaeal elongation factor
the impairment of the ternary complex formation was the target of
this antibiotic action [28].
Regarding the effect of the antibiotic on the interaction with
guanosine nucleotides, the results obtained indicated that pulvo-
mycin increased the rate of nucleotide exchange for both GDP and
GTP. More pronounced effects were instead observed when the
GTPaseNa was used as a probe to study the antibiotic interaction. In
particular, pulvomycin was able to stimulate the intrinsic NaCl-
dependent GTPase catalysed by SsEF-1a, a ﬁnding that was already
reported for the intrinsic GTPase of EcEF-Tu [33], even though in that
case the stimulatory effect was more pronounced. However, the
stimulatory effect exerted by pulvomycin cannot be detected for the
catalytic activity elicited by the truncated forms of SsEF-1a lacking
the C- or the C- and M-domains. These results indicated that the
integrity of the elongation factor was required to observe the effect,
and that the C-terminal domainwas essential for the interaction. The
analysis of the energetic parameters of activation could give an
explanation of the increased hydrolytic rate of the reaction,
measured in thepresence of pulvomycin. Indeed, the reduced energy
of activation, induced by the antibiotic, was essentially due to
a reduced enthalpy of activation, even though an unfavourable
entropy factor leads to an unvaried free energy of activation.
The interaction between the archaeal elongation factor and
pulvomycin was also demonstrated by the ﬁnding that the antibi-
otic rendered SsEF-1a slightly more resistant to guanidine hydro-
chloride denaturation. This ﬁnding is indicative of a more compact
molecular organisation of the elongation factor observed in the
presence of pulvomycin. However, a direct stabilising effect of the
antibiotic on the protein in the complex cannot be excluded.
Finally, the data obtained from ﬂuorescence spectroscopy, sug-
gested a conformational change induced by the antibiotic upon its
interaction with SsEF-1a and conﬁrmed those already reported for
EcEF-Tu [8,33]. However, the integrity of the archaeal elongation
factor is required to bind the antibiotic with higher afﬁnity.
Furthermore, the appearance of a ﬂuorescence band at 360 nm in
the presence of pulvomycin for all proteins investigated, is indica-
tive of the exposition to the aqueous solvent of tryptophan residues,
even though a resonance energy transfer between close tyrosines
and tryptophan(s) residues [26] cannot be excluded. In the primary
structure of SsEF-1a two tryptophans and ten tyrosines were
present, most of them in the nucleotide binding domain (W209,
Y84, Y122, Y161, Y166, Y180, Y210, Y218). Therefore, the ﬁnding that
the appearance of the 360 nm band was also evident on the trun-
cated forms of the elongation factor, indicated that the main target
of the solvent exposition upon antibiotic binding, was the region
comprising Trp209 (Fig. 9) to which the resonance energy transfer
could occur from tyrosines 161, 166 and 210, surrounding this
residue.
5. Conclusions
In conclusion, the data presented strongly indicated a molecular
interaction between an archaeal elongation factor 1a and the
eubacterial antibiotic pulvomycin. These ﬁndings, besides being
useful for studying the interaction between pulvomycin and
eukaryotic elongation factor 1a, could be used as probe to inves-
tigate phylogenetic relationships among living domains.
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a b s t r a c t
Structural characterizations of thioredoxins (Trxs) are important for their involvement in severe pathol-
ogies and for their stable scaffold. Here we report a combined structural and spectroscopic characteriza-
tion of a Trx isolated from the hyperthermophilic archaeon Sulfolobus solfataricus (SsTrxA1). Thermal
denaturation unveils that SsTrxA1 is endowed with a remarkable stability in the explored temperature
range 50–105 C. The structure of the oxidized form of SsTrxA1 determined at 1.9 Å resolution presents
a number of peculiar features. Although the protein was crystallized in a slightly acid medium (pH 6.5) as
many as ten intramolecular/intermolecular carboxyl–carboxylate interactions involving glutamic and
aspartic acid side chains are found in three independent SsTrxA1 molecules present in the asymmetric
unit. Surprisingly for a hyperthermostable protein, the structure of SsTrxA1 is characterized by the pres-
ence (a) of a very limited number of intramolecular salt bridges and (b) of a cavity nearby Cys52, a residue
that is frequently a phenylananine in other members of the family. Chemical denaturation investigations
carried out on SsTrxA1 and SsTrxA2 show that both proteins present a significant stability against guani-
dine hydrochloride, thus indicating that ionic interactions play a minor role in their stabilization. Com-
pared to Trxs from mesophilic sources, SsTrxA1 displays a longer a-helix 1 and a shorter loop
connecting this a-helix with b-strand 2. As these features are shared with Trxs isolated from thermophilic
sources, the shortening of this loop may be a general strategy adopted to stabilize this fold. This feature
may be exploited for the design of hyperthermostable Trx scaffolds.
 2011 Elsevier Inc. All rights reserved.
1. Introduction
The ubiquitous thioredoxin (Trx) protein family is a member of
the thioredoxin fold class of oxidoreductases (Arner and Holmgren,
2000; Carvalho et al., 2006a; Tang and Altman, 2011). The interest
for Trxs is twofold. Not only are Trxs involved in fundamental bio-
logical processes, but their fold has also been used in interesting
applications in protein engineering. In the protein engineering
field, the stable fold of these proteins has been exploited in several
biotechnological applications (Colas et al., 1996; LaVallie et al.,
1993; Moretto et al., 2007).
From the biological point of view, these proteins play a key role
in redox regulation of protein activity and redox signaling (Arner
and Holmgren, 2000). In particular, the thioredoxin system, com-
posed by Trx, thioredoxin reductase (TrxR), and NADPH, is essen-
tial for regulating the redox state of the cell and in protecting
against oxidative stress. In this scenario, it is not surprising that
Trxs are linked to a variety of disorders (Lillig and Holmgren,
2007; Maulik and Das, 2008).
Investigations carried out on Trxs isolated form thermophilic
organisms simultaneously provide information on their biological
role and on a possible strategy to generate scaffolds endowed with
enhanced stability. It is important to note that, although the Trx
system has been discovered decades ago, most of the functional
and structural investigations have been performed on eukaryal
and eubacteryal Trx systems. Indeed, only limited data are
1047-8477/$ - see front matter  2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.jsb.2011.10.014
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available for proteins involved in the Trx system of archaea, despite
more recent work suggests that disulfide bond formation may con-
tribute to the stabilization of proteins even in intracellular envi-
ronments (Ladenstein and Ren, 2006). We have recently
undertaken the functional and structural characterization of the
intricate Trx system of the hyperthermophilic archaeon Sulfolobus
solfataricus. This system includes two distinct Trxs (SsTrxA2 and
SsTrxA1) and three potential TrxRs (SsTrxRB1, SsTrxRB2, and
SsTrxRB3) (Grimaldi et al., 2008; Ruocco et al., 2004). In our previ-
ous studies we have shown that SsTrxA2 and SsTrxA1 are both sub-
strates for SsTrxRB3 (Grimaldi et al., 2008). On the other hand, the
other two potential TrxRs (SsTrxRB1 and SsTrxRB2), which share a
significant sequence identity with members of the TrxR superfam-
ily, are unable to reduce either SsTrxA2 or SsTrxA1 (Grimaldi et al.,
2008). Notably, independent studies have also shown that
SsTrxRB3 is able to reduce a PDO-like protein (Pedone et al.,
2006). In order to relate the functional properties of these enzymes
to their three-dimensional structures and to elucidate the struc-
tural basis of their thermostability, we have also undertaken crys-
tallographic investigations on the protein components of the
S. solfataricus thioredoxin system (Ruggiero et al., 2005; Ruggiero
et al., 2009a,b,c). We have previously described the crystal struc-
ture of SsTrxRB3, which has provided insights into the determi-
nants of its dual function (thioredoxin reductase and NADH
oxidase) and thermostability (Ruggiero et al., 2009b). Moreover,
we have also characterized the peculiar dimeric structure of
SsTrxA2 (Ruggiero et al., 2009a). We here report a combined struc-
tural and spectroscopic characterization of SsTrxA1. This analysis
suggests that the extraordinary thermal stability of SsTrxA1 relies
on the extension of a specific helix (helix 1) and on the shortening
of a loop. As these features are shared with Trxs isolated from ther-
mophilic sources, we suggest that these features represent a com-
mon strategy adopted by the evolution to stabilize the Trx
structure that can be exploited for the design of hyperthermostable
Trx scaffolds.
2. Materials and methods
2.1. Protein expression, purification, and crystallization
SsTrxA1 expression, purification, and crystallization experi-
ments have been conducted as previously reported (Grimaldi
et al., 2008). SsTrxA1 structure was solved by molecular replace-
ment as previously described (Ruggiero et al., 2009c).
2.2. Structure refinement
The refinement of the structure was carried by using the pro-
gram CNS (Brunger, 2007). Refinement runs were followed by
manual intervention using the molecular graphic program O (Jones
et al., 1991) to correct minor errors in the position of the side
chains. Water molecules were identified by evaluating the shape
of the electron density and the distance of potential hydrogen bond
donors and/or acceptors. The inspection of the maps clearly indi-
cated that, with the exception of few terminal residues or few
exposed side chains, the electron density is well-defined for the en-
tire protein. Crystallographic and stereo-chemical statistics of the
final models are reported in Table 1. The coordinates of the model
and the experimental structure factors of SsTrxA1 have been
deposited in the Protein Data Bank with the code 3TCO.
2.3. Circular dichroism spectra and denaturation
SsTrxA1 CD spectra were recorded with a Jasco J-810 spectropo-
larimeter equipped with a Peltier temperature control system
(Model PTC-423-S). Molar ellipticity per mean residue, [h] in
deg cm2 dmol1, was calculated from the equation:
[h] = [h]obsmrw(10lC)
1, where [h]obs is the ellipticity measured
in degrees, mrw is the mean residue molecular mass (108.5 Da),
C is the protein concentration in g l1 and l is the optical path
length of the cell in cm. Far-UV measurements (198–250 nm) were
carried out using a 0.1 cm optical path length cell and a protein
concentration of 0.30 mg ml1. Other parameters of the CD spectra
registration are identical to those adopted in our previous studies
(Granata et al., 2006, 2008) . Thermal denaturation curves were re-
corded over the 50–105 C temperature range following the CD sig-
nal at 222 nm. The curves were registered using a 0.1 cm path
length cell and a scan rate of 1.0 C min1.
Chemical denaturation was carried out by treating the SsTrxA1/
SsTrxA2 with guanidine hydrochloride (GuHCl). A commercial 8 M
GuHCl solution (from Sigma) was utilized. Stock solutions of
GuHCl, in different amounts, were mixed with protein solutions
to give a constant final value of the protein concentration
(0.15 mg ml1). The final concentration of GuHCl was in the range
0.0–7.0 M. All the chemical denaturation experiments were carried
out in 20 mM sodium phosphate (pH 7.0) buffer after overnight
incubation. The GuHCl-induced denaturations was investigated
by CD spectroscopy by following the signal at 220 nm.
3. Results and discussion
3.1. Overall structure
As previously reported (Ruggiero et al., 2009c), the N-terminal
fragment of SsTrxA1 (residues 1–24) is frequently cleaved from
the thioredoxin domain upon protein expression and purification.
As for SsTrxA2 (Ruggiero et al., 2009c), well diffracting crystals of
SsTrxA1 were obtained only for the truncated form of the protein.
On the basis of electron density maps, an accurate tracing could
be obtained for the region Lys27–Leu132 for the three copies of the
protein, present in the asymmetric unit (hereafter denoted as mol-
ecule A, B, and C) (Fig. 1A). Although some extra electron density is
evident at the C-terminus of Leu132 for all three chains, residue
Lys133 has been built only for molecule A. With the exception of
few solvent-exposed side chains, the electron density is well de-
fined for all protein residues (Fig. 1B). SsTrxA1 stereochemical
parameters are in line with those reported for well refined protein
Table 1
Data collection and refinement statistics.
Data collection statistics
Space group P21
Cell parameters
a(Å), b(Å), c(Å), b() 51.77, 75.09, 55.35, 112.64
Resolution range (Å) 25.0–1.90
Number of molecules in the asymmetric unit 3
Number of unique observations 28,606
Rmerge
a 9.7
Refinement statistics
Resolution range (Å) 25.0–1.90
Rfactor
b/Rfree
c 0.189/0.222
Number of protein atoms 2543
Number of water molecules 233
Number of ethylene glycol molecules 8
Root mean square deviations from ideality
Bonds (Å) 0.0079
Angles () 1.30
a Rmerge = RhklRi|Ii(hkl)  hI(hkl)i|/RhklRiIi(hkl), where Ii(hkl) is the intensity of an
observation and hI(hkl)i is the mean value for its unique reflection; summations are
over all reflections.
b Rfactor = Rh||Fo(h)|  |Fc(h) ||/Rh|Fo(h)|, where Fo and Fc are the observed and
calculated structure-factor amplitudes, respectively.
c Rfree was calculated with 5% of the data excluded from the refinement.
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structures. The three independent molecules of the asymmetric
unit display very similar structures. Indeed, pairwise RMSD values,
calculated on the Ca atoms, between these molecules are in the
range 0.36–0.56 Å. Unless otherwise specified, the features of mol-
ecule A will be described throughout the text.
As expected from the significant sequence identity with other
members of the family, SsTrxA1 adopts a typical thioredoxin fold
characterized by a central five-stranded b-sheet with a """;" topol-
ogy surrounded by four a-helices (Fig. 1A). The analysis of SsTrxA1
redox center clearly indicates that the reactive disulfide bridge
Cys57–Cys60 of the three molecules is in its oxidized state
(Fig. 1B). This finding is not surprising as crystallization experi-
ments were conducted in air. In addition to the two cysteine resi-
dues that are involved in the redox center, in TrxA1 sequence there
is an extra cysteine residue (Cys52) which is only five residues far
from Cys57 of the redox center. The analysis of SsTrxA1 structure
indicates that Cys52 is oriented in such a way that it does not inter-
fere with the Cys57–Cys60 disulfide bridge (Fig. 1B). Indeed, the
distance between Cys52 side chain and the disulfide bridge of
the redox center is 10 Å. It is important to note that Cys52 is re-
placed by a bulky Phe residue (i.e. Phe27 in E. coli Trx) in Trxs with
known three-dimensional structures (Fig. 2). This unusual muta-
tion, which is found in only 11 over 1046 annotated bacterial/
archaeal Trx sequences, is likely to generate a cavity in the protein
core. Indeed, a comparison of SsTrxA1 and E. coli Trx structures
shows that the replacement of a bulky Phe side chain with a Cys
creates a pocket of about 24 Å3 in the TrxA1 structure (Fig. 3).
The analysis of SsTrxA1 structure indicates that there is no local
rearrangement to fill the cavity. A careful inspection of the electron
density map of the cavity indicates that no ordered water molecule
is located inside. This is not surprising considering the hydrophobic
nature of the side chains of the residues (Leu83, Val85, Ile91, Ala92,
Tyr 95, Val 97 and Leu104) that delimitate this pocket. It is impor-
tant to note that amino acid replacement that produce similar cav-
ities in the structure of T4 lysozyme significantly destabilize the
enzyme (DTm  10 C) (Eriksson et al., 1992). Therefore, it is some-
what surprising that even proteins endowed with extraordinary
thermal stability may tolerate cavities in their 3D structures.
3.2. Comparison with other Trx structures
The comparison of SsTrxA1 with SsTrxA2 (Ruggiero et al.,
2009a) and Trxs isolated from Sulfolobus tokodaii (StTrx) (Ming
et al., 2007), Escherichia coli (EcTrx) (Katti et al., 1990), Thermus
thermophilus (TtTrx) (Yanai, H., Yokoyama, S., Kuramitsu, S. PDB
code 2CVK), and spinach chloroplast M (SpTrx) (Capitani et al.,
2000) yields root mean square deviation (RMSD) values in the
range of 0.74–1.08 Å. This is in line with the sequence identity de-
tected between SsTrxA1 and these Trxs (38–45%) (Fig. 2). A de-
tailed comparison of secondary structure elements of these
proteins clearly indicates that they are well conserved in the family
(Fig. 2). The only significant difference is detected for the a-helix 1,
that is significantly shorter in Trxs isolated from mesophilic
sources (EcTrx and SpTrx), (Fig. 2). Consequently the loop that
connects this helix with strand 2 in mesophilic Trxs is virtually
absent in Trxs (TtTrx, StTrx, SsTrxA2, SsTrxA1) isolated from ther-
mophilic organisms (Figs. 2 and 4). In line with our previous pro-
posal (Ruggiero et al., 2009c), these findings suggest that the
extension of the a-helix 1 and the consequent elimination of the
loop may be related to the stability of these proteins. It is impor-
tant to note that the local sequences of the proteins that exhibit
a longer helix also present a deletion of a single residue in this re-
gion. The observation that the local sequences of both thermophilic
and mesophilic Trxs present a significant level of variability may
indicate that the deletion of a residue in this region may be suffi-
cient for the elongation of the helix and, possibly, for increasing
the fold stability.
3.3. SsTrxA1 crystal packing and oligomeric state
Previous characterizations of SsTrxA1 and SsTrxA2 by gel filtra-
tion showed that the elution behavior of both proteins was indic-
ative of a dimeric state (Grimaldi et al., 2008). Accordingly, the
crystallographic analysis of SsTrxA2 led to the identification of a
symmetric dimeric assembly in the crystalline state (Ruggiero
et al., 2009a) whose stability was validated by analyses of the inter-
face carried out using the program PISA (Krissinel and Henrick,
2007). The inspection of SsTrxA1 crystal packing of the three
independent molecules present in the asymmetric unit did not lead
to the identification of symmetric dimers. Nevertheless, significant
intermolecular interactions are detected in the crystal state (Table
2). Interestingly, these interactions are not random between crystal
mates, but they are recurrent. Indeed, as reported in Table 2, the
interface detected between molecule A and B closely resembles
the one formed by molecules B and C and by molecule C and copy
of molecule A (A#) generated by the translation along the a axis.
This packing leads to the generation of a polymer-like assembly
of SsTrxA1 that extends for the entire crystal (Fig. S1). The interface
area calculated by using the program PISA is 450 Å2. In addition
to the hydrogen bonding interactions, each recurrent interface is
characterized by the presence of two molecules of ethylene glycol,
that was used as cryoprotectant in freezing the crystals. The posi-
tion of these ethylene glycol molecules is stabilized by H-bonding
interactions with protein atoms and, occasionally, with water mol-
ecules. In addition, they make extensive contacts with hydrophobic
atoms that are exposed in the protein monomers. The similar
Fig. 1. Overall structure of the three molecules within the asymmetric unit (A) and
the 2Fo–Fc omit electron density map of disulfide bond of molecule A countered at
1.7r (B).
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location of these two ethylene glycol molecules in the three recur-
rent interfaces A–B, B–C, and C–A# confirms their high similarity.
In addition to these six ethylene glycol molecules located at the
recurrent interface two additional molecules have been found in
other packing regions of the asymmetric unit.
3.4. A peculiar feature of SsTrxA1 structure: carboxyl–carboxylate
interactions
An interesting feature of SsTrxA1 structure is the presence of an
unusual high number of carboxyl–carboxylate interactions (Table
3), despite the rather standard conditions used for protein crystal-
lization (30% (w/v) PEG4000 and 0.2 M (NH4)2SO4 – pH of the
solution 6.5). Although there are several examples of carboxyl–
carboxylate interactions in protein structures (Flocco and Mowbray,
1995), occasionally with important physiological roles (Ito et al.,
1995; Mazzarella et al., 2006b; Vergara et al., 2010) and even at
rather high pH values (Mazzarella et al., 2006a), the structure of
SsTrxA1 is characterized by a peculiar abundance of these pairs.
As reported in Table 3, there are seven intra-molecular and four
intermolecular carboxyl–carboxylate interactions. In the three recur-
rent interfaces of the polymer-like association the side chain of
Asp113 is bonded to the side chain of Glu36. At the B–C interface,
the side chain of Asp113 also binds the side chain of Glu40. Two
intramolecular interactions, those linking Glu27 to Glu72 and
Glu121 to Glu125, are conserved in the three molecules of the
asymmetric unit. On the other hand, the interaction between
Asp51 and Glu64 side chain is observed only in molecule A.
Asp51 has the same conformation in the three molecules of the
asymmetric unit. This conformation is also similar to that observed
for the corresponding residue (Asp26) in EcTrx. On the other hand,
Glu64 protrudes toward the solvent in molecules B and C. The close
similarity of the local structure of the three SsTrxA1 molecules sug-
gests that the energy of the two rotameric states of Glu64 is regu-
lated by minor local effects. It is important to note that in EcTrx the
ionization of Asp26 affects the stability of the thiolate anion of
Cys32 in EcTrx (Cys57 in SsTrxA1) (Carvalho et al., 2006b; Holm-
gren, 1995) (Chivers and Raines, 1997; Chivers et al., 1997). Indeed,
the deprotonation of Cys32 may be hampered by a deprotonated
Asp. Current resolution does not provide insights into the proton-
ation of these two carboxylic groups (Asp51 or Glu64) that interact
in molecule A. Nevertheless, the formation of the bond attenuates
Fig. 2. Sequence alignment of SsTrxA1, SsTrxA2, EcTrx, SpTrxm, TtTrx, and StTrx. a-helices and b-sheets are denoted in green and yellow, respectively. The residue numbering
refers to SsTrxA1 sequence. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3. Superimposition of SsTrxA1 (cyan) with EcTrx (red). The residues that
delimitate the cavity created by the replacement of Phe27 EcTrx with Cys52
SsTrxA1 are drawn in ball-and-stick in SsTrxA1 structure. (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of
this article.)
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the charge on Asp, thus facilitating the deprotonation of nucleo-
philic Cys57 which is responsible for the attack of the disulfide
bond of the substrate.
3.5. Salt bridges in SsTrxA1 structure
Over the years, several structural determinants of protein sta-
bilization have been proposed and evaluated (Petsko, 2001; Kumar
and Nussinov, 2001). Although these analyses have unveiled that
no mechanism has a general validity, it seems that an important
role in protein stabilization is played by the occurrence of salt
bridges (Kumar et al., 2000; Kumar and Nussinov, 2004). Moreover,
previous studies have suggested that electrostatic interactions may
be responsible for the remarkable stability of StTrx (Ming et al.,
2007). As SsTrxA1 is endowed with a remarkable thermal stability
(see also below) we carried out a detailed analysis of the ion pairs
in SsTrxA1. As shown in Table 4, the three independent molecules
in the asymmetric unit present on average only three intramolec-
ular salt bridges. Moreover, there is a single ion pair (Glu27–Lys75)
that is observed in all three independent copies of SsTrxA1. Collec-
tively, the finding that these ion pairs are weakly conserved among
different independent molecules of SsTrxA1 in the crystal state and
that their total number is in line with that observed in mesophilic
Trx does not provide support to a possible role of these interactions
in the thermostabilization of SsTrxA1.
3.6. Spectroscopic characterization of SsTrxA1 by using circular
dichroism
In order to gain further insights into the determinants of SsTrxA1
stability, we also carried out a spectroscopic characterization of the
protein by using circular dichroism. In line with previous biochem-
ical observations, this analysis confirms that SsTrxA1 is endowed
with a remarkable thermostability (Fig. 5). Indeed, the direct com-
Fig. 4. Superimposition of SsTrxA1 structure (blue) with the 3D models of SsTrxA2
(red), EcTrx (green), SpTrxm (cyan), TtTrx (yellow), and StTrx (magenta). It is evident
that helix 1, highlighted in the snapshot, is longer in Trxs isolated from
thermophilic organisms. Residues of helix 1 of SsTrxA1 and EcTrx are drawn in
blue and green, respectively.
Table 2
Recurrent intermolecular H-bond interactions between different molecules in TrxA1
crystals.
Residues and atoms Distance (Å)
Molecules A–B Gln110 NE2–Ala78 O 3.05
Leu111 O–Asn45 ND2 2.85
Val112 O–Asn37 ND2 2.99
Asp113 OD1–Glu36 OE1 2.81b
Molecules B–C Gln110 NE2–Ala78 O 2.90
Leu111 O–Asn45 ND2 2.86
Val112 O–Asn37 ND2 2.88
Ser114 OG–Glu40 OE1 2.26
Asp113 OD1–Glu36 OE1 2.65b
Asp113 OD1–Glu40 OE1 3.04b
Molecules C–A#a Gln110 NE2–Ala78 O 3.15
Leu111 O–Asn45 ND2 2.83
Val112 O–Asn37 ND2 2.90
Ser114 OG–Glu40 OE1 2.53
Asp113 OD1–Glu36 OE1 2.56b
a A# denotes a symmetry copy of A. The symmetry operation is a translation
along the a axis.
b These H-bonds are generated by carboxyl–carboxylate interactions (see the text
for details).
Table 3
Carboxyl–carboxylate interactions.
Residues Distance (Å)
Intra-molecular
Molecule A Glu27–Glu72 2.76
Asp51–Glu64 2.81
Glu121–Glu125 2.85
Molecule B Glu27–Glu72 2.93
Glu121–Glu125 2.84
Molecule C Glu27–Glu72 2.69
Glu121–Glu125 2.48
Inter-molecular
Interface A–B Asp113–Glu36 2.81
Interface B–C Asp113–Glu36 2.65
Asp113–Glu40 3.04
Interface C–A# a Asp113–Glu36 2.56
a A# denotes a symmetry copy of A. The symmetry operation is a translation
along the a axis.
Table 4
Salt bridges.
Residues Distance
Intra-molecular
Molecule A Glu27–Lys75 2.81
Lys73–Glu125 2.46
Lys73–Glu121 3.33
Molecule B Glu27–Lys75 2.68
Lys69–Glu121 3.20
Molecule C Glu64–Lys68 3.43
Lys69–Glu121 2.53
Lys73–Glu121 2.82
Lys73–Glu125 2.86
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parison of the far-UV CD spectrum of the protein kept for one hour
at 105 C is very similar to that collected at 70 C. Accordingly, a
thermal denaturation experiment carried out in the temperature
range 50–105 C only reveals a negligible variation of the CD signal
at 220.
We then evaluated the effect of a charged chemical denaturant
(GuHCl), which is commonly supposed to weaken protein salt
bridges (Ibarra-Molero et al., 1999; Makhatadze et al., 1998), on
the stability of SsTrxA1. The analysis of the CD spectra unveils that
the secondary structure elements of SsTrxA1 are virtually un-
changed by the addition of GuHCl up to 4 M (Fig. 6A). Denaturating
effects are detected for higher concentrations. Similar experiments
conducted on SsTrxA2, which also presents a limited number of
salt bridges, led to similar results (Fig. 6B). The significant stability
of both SsTrxA1 and SsTrxA2 against GuHCl suggests that the con-
tribution of salt bridges to the stability of both proteins may be
limited.
4. Conclusions
The spectroscopic and crystallographic characterization of
SsTrxA1 suggests that ion pairs do not contribute to the remarkable
thermal stability of the enzyme. On the basis of the present struc-
ture and of comparisons of Trx structures isolated from either ther-
mophilic or mesophilic organisms, we suggest that other effects,
such as the shortening or removal of the loop connecting second-
ary structure elements, play a role in SsTrxA1 stability. The close
similarity of secondary structure content in other thermophilic
Trxs such as SsTrxA2, StTrx, and TtTrx suggests that this mecha-
nism may be of general validity within this widespread protein
family. Along this line, it has been shown that secondary structure
content has also an important role in the stabilization of Alicycloba-
cillus acidocaldarius Trx (Leone et al., 2004). This observation may
have an important impact in the design of Trx variants endowed
with an increased stability. Indeed, on analogy with the result of
the evolution, the shortening of the loop connecting the a-helix
1 and the b-strand 2 may increase the stability of Trx scaffolds used
for biotechnological applications. Under this regard, it is relevant
that the addition of SsTrxA2 to cultured neuroblastoma cells pro-
tected them from the oxidative stress induced by diclofenac, an
anti-inflamatory drug (Cecere et al., 2010).
Finally, it is important to note that it has been previously shown
that the thermostability of SsTrxRB3 (Ruggiero et al., 2009b), the
enzyme that reduces both SsTrxA1 and SsTrxA2, likely relies on
clusters of interacting ion pairs. Collectively, these observations
suggest that the thermostability of functionally related proteins
isolated from the same organism can be based on different struc-
tural determinants.
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The interaction between tetracycline and the ar-
chaeal elongation factor 1a from Sulfolobus solfa-
taricus was investigated. The effects produced by
this eubacterial antibiotic indicated that this inter-
action involved the G-domain of the elongation
factor 1a from S. solfataricus, although also the M-
domain was required. In fact, in the presence of the
antibiotic, an increase in the fluorescence quantum
yield of the aromatic region was observed for elon-
gation factor 1a from S. solfataricus and its trun-
cated form lacking the C-terminal domain, but not
for that lacking also the M-domain. The increase in
quantum yield was restored when the G-domain of
elongation factor 1a from S. solfataricus was fused
to the M and the C-domains of the eubacterial ana-
logue elongation factor Tu. Tetracycline inhibits
protein synthesis catalysed by elongation factor 1a
from S. solfataricus; this is accompanied by an
increase in the GDP/GTP exchange rate and a slight
inhibition of the intrinsic GTPase, suggesting that
a main effect of the antibiotic was exerted on the
GTP-bound form of the enzyme. Furthermore, the
mixed inhibition observed for GTPase confirmed
that the interaction, besides the G-domain,
involved also other region(s) of elongation factor
1a from S. solfataricus. These results can be useful
for studying potential side effects arising from the
interaction between tetracycline and eukaryotic
elongation factors.
Key words: antibiotic, elongation factor 1a, protein synthesis, Sulf-
olobus solfataricus, tetracycline
Abbreviations: Ec, Escherichia coli; EcEF-Tu, Escherichia coli EF-
Tu; EF, elongation factor; GTPaseNa, NaCl-dependent GTPase of SsEF-1a;
SsEF-1a, elongation factor 1a from Sulfolobus solfataricus.
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Translation elongation factor 1a from Sulfolobus solfataricus (SsEF-
1a) is the functional homologue of the eubacterial elongation factor
Tu (EF-Tu) that belongs to the family of GTP-binding proteins (1).
The primary role of SsEF-1a ⁄ EF-Tu is the delivery of the aminoacyl-
tRNA to the A site of mRNA-programmed ribosome during the elon-
gation cycle (2,3), even though for both enzymes, other biological
functions have been reported (4–6). The crystal structure of SsEF-
1a ⁄ EF-Tu showed the presence of three structural domains (7–10):
a GDP ⁄GTP-binding domain (G-domain), a middle (M) and a C-termi-
nal (C) domain; in the fulfilment of its main role, SsEF-1a ⁄ EF-Tu, in
its active form bound to GTP, elicits a GTPase activity that produces
the corresponding GDP-bound form that dissociates from the ribo-
some. The switch from the active to the inactive form is associated
with a conformational change of the enzymes (11). The regeneration
of the active form is ensured by the intervention of the elongation
factor Ts ⁄ 1b which catalyses the GDP ⁄GTP exchange on the factor.
The details of the mechanism of action of Escherichia coli EF-Tu
(EcEF-Tu) have also been investigated taking advantage of specific
antibiotics acting on the elongation factor; in particular, kirromycin
hinders the dissociation of EF-Tu•GDP from the mRNA-programmed
ribosome inducing a GTP-bound conformation on EF-Tu (12). Pulv-
omicyn and GE2270A interfere with ternary complex formation both
preventing the interaction between EF-Tu•GTP and aa-tRNA (12,13).
More recently, the resolution of the three-dimensional structure of
a complex formed between tetracycline and the EF-Tu•GDP complex
(14) reopens the question of the molecular target(s) of this antibi-
otic that probably reflects different modes of action and ⁄ or resis-
tant mechanisms in different pathogens (14). In fact, over the years
several studies have been reported in which ribosomal proteins
(15–17) or specific sites of 16S rRNA molecules (18–23) are claimed
to be involved in the weak interaction between tetracycline and
ribosome (24). Therefore, the resolution of the structure of a com-
plex between tetracycline and EF-Tu in its GDP-bound form (14)
revalued early reports focusing on the involvement of this elonga-
tion factor in the mechanism of action of tetracycline (25–31). The
details of the molecular contacts between the antibiotic and the
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elongation factor pointed to a binding site entirely located on the
G-domain of EF-Tu; however, the crystallographic unit contains an
(EF-Tu•GDP•tetracycline)2 dimer in which intramolecular contacts
are formed by the two G and the two M-domains of the EF-Tu mol-
ecules in the dimer. Therefore, the packaging of the complex might
involve different portions of the proteins and it is not restricted to
the nucleotide-binding domain of the elongation factor.
Regarding the interaction between archaeal protein synthesis elon-
gation factors and eubacterial antibiotics, we have reported that
kirromycin was able to enhance the intrinsic GTPase activity of
some SsEF-1a mutants, but not that of the wild-type enzyme (32–
34); vice versa, GE2270A was found to increase the GDP ⁄GTP
exchange rate and to reduce the intrinsic GTPase of the archaeal
elongation factor (35). In addition, fusidic acid, another eubacterial
antibiotic acting on the elongation factor G, was found to interact
with its archaeal functional analogue SsEF-2 (36). It has to be
noted that in an in vitro reconstituted system, none of these three
antibiotics were able to inhibit protein synthesis in S. solfataricus
(37); vice versa, it has been reported that tetracycline was able to
inhibit protein synthesis in an in vitro cell-free reconstituted system
in S. solfataricus (37) and Sulfolobus acidocaldarius (38), even
though the concentration of antibiotic leading to half inhibition was
at least one order of magnitude higher than that reported for eu-
bacterial protein synthesis. All these considerations prompted us an
investigation into the interaction between tetracycline and SsEF-1a.
The results obtained indicated that the antibiotic interacts with the
archaeal elongation factor, as revealed by fluorescence analysis but
also based on the influence that tetracycline exerted on specific
partial reactions catalysed by the elongation factor. Finally, the
availability of engineered forms of SsEF-1a confirmed that the mid-
dle domain of the elongation factor is important for the interaction
with the antibiotic.
Materials and Methods
Chemicals, buffers and enzymes
Labelled compounds and chemicals were as already reported (39).
Tetracycline (Sigma–Aldrich, Milan, Italy) was prepared as 50 mM
stock solution in water and stored at )80 C. The antibiotic con-
centration was assessed by absorbance reading at 360 nm, using a
molar extinction coefficient of 15.80 1 ⁄mM•cm (40). The following
buffers were used: Buffer A: 20 mM Tris•HCl, pH 7.8, 50 mM KCl,
10 mM MgCl2; buffer B: 20 mM Tris•HCl, pH 7.8, 10 mM MgCl2,
1 mM DTT, 3.6 M NaCl.
Elongation factor 1a from S. solfataricus and its engineered or chi-
maeric forms were produced and purified as already reported
(39,41,42). SsRibosome, SstRNA, SsEF-2 and SsFRS were purified
as reported (43,44).
SsEF-1a assays
The preparation of [3H]Val–EctRNAVal, the formation of the ternary
complex SsEF-1a•Gpp(NH)p•[3H]Val–EctRNAVal and the protection
against spontaneous deacylation of [3H]Val–EctRNAVal were carried
out as already described (45). Poly(U)-directed poly([3H]Phe) synthe-
sis was assayed as reported (35,43).
The ability of SsEF-1a to bind [3H]GDP or to exchange the radiola-
belled nucleotide for GDP or GTP was assayed by nitrocellulose fil-
tration as described (39). The apparent equilibrium dissociation
constant (K'd) of the binary complex formed between SsEF-1a and
[3H]GDP was determined by Scatchard plots titrating 1.0 lM SsEF-
1a with 0.4–4 lM [3H]GDP (specific radioactivity 7443 cpm ⁄ pmol).
K'd for GTP was derived from competitive binding experiments in
which 0.5 lM SsEF-1a was incubated in the presence of 14 lM
[3H]GDP (specific radioactivity 1183 cpm ⁄ pmol) and different con-
centrations (40–300 lM) of GTP.
The intrinsic GTPase of SsEF-1a was measured in the presence of
3.6 M NaCl (GTPaseNa) as reported (46). The kinetic parameters
were determined in buffer B using 0.5 lM SsEF-1a and 1.5–30 lM
[c–32P]GTP (specific radioactivity 8582–551 cpm ⁄ pmol). The reaction
was followed kinetically at 60 C and the amount of 32Pi released
determined on 50–lL aliquots.
The effect of tetracycline on the heat inactivation of SsEF-1a was
evaluated by incubating 4 lM protein in buffer A at selected tem-
peratures in the 87–96 C interval. After the heat treatment, 40-lL
aliquots were cooled on ice for 30 min and then analysed for their
residual [3H]GDP-binding ability or GTPaseNa as reported earlier. The
data were analysed through a first-order kinetic equation, and the
rate constants of the heat inactivation process obtained (kin) were
used to draw an Arrhenius plot, from which the energetic parame-
ters of activation can be derived as reported (39).
Fluorescence spectra were recorded on a Cary Eclipse spectrofluo-
rimeter (Varian Inc., Mulgrave, Australia) at a scan rate of
60 nm ⁄min using an excitation wavelength of 280 nm; excitation
and emission slits were set to 10 nm. Blanks run in the absence of
the protein were subtracted. Spectra recorded in the presence of
tetracycline were corrected for the inner filter effect because of the
absorbance of the antibiotic, using a molar absorption coefficient at
280 nm of 17.49 1 ⁄mM•cm determined from a linear Beer–Lambert
plot of absorbance versus tetracycline concentration.
Results
Effects of tetracycline on the molecular
properties of SsEF-1a
The effect of tetracycline on the molecular properties of SsEF-1a
was studied by fluorescence spectroscopy. As shown in Figure 1A,
a 4–molar excess of antibiotic over protein concentration induced a
less than 1 nm red shift with a 10% increase in the quantum yield,
in the aromatic region of the fluorescence spectrum (kmax 314 nm).
This behaviour was also observed for the eubacterial counterpart
EcEF-Tu (Figure 1D, kmax 310 nm) for which the interaction with the
antibiotic was also observed crystallographically (14). The availabil-
ity of (i) two truncated forms of SsEF-1a lacking either the C-termi-
nal (Ss(GM)EF-1a) or both the middle and C-terminal domains
[Ss(G)EF-1a, (39)] or (ii) a chimaeric form constituted by the
G-domain of SsEF-1a and the M and C-domains of EcEF-Tu (41)
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allowed the identification of the protein's portion involved in the
interaction between the elongation factor and tetracycline. In fact,
in the case of Ss(GM)EF-1a (Figure 1B, kmax 310 nm), the antibiotic
induced a similar quantum yield increase with respect to the intact
factor; on the other hand, this increase was not observed with the
truncated form lacking both M and C-terminal domains (Figure 1C,
kmax 314 nm). These results indicated that the domain M of the
elongation factor is essential to observe the interaction between
SsEF-1a and the antibiotic. Concerning the chimaera, a result simi-
lar to the intact factors was observed (Figure 1E, kmax 330 nm),
although the antibiotic produced a slight higher blue shift (7 nm);
this finding indicated that tetracycline induced a more compact con-
formation on the chimaeric elongation factor.
For all proteins investigated, except the domain G of SsEF-1a, an
increase in the quantum yield at increasing tetracycline concentration
with a saturation behaviour was observed (Figure 2A). In fact, using a
double reciprocal plot, straight lines were obtained (Figure 2B). From
the intercept on the abscissa axis, a value of the tetracycline concen-
tration to reach half the maximum fluorescence can be derived; in
particular, the value derived for SsEF-1a (229 lM, Fmax 490) was sig-
nificantly higher than that found for the chimaera (104 lM, Fmax 378),
EcEF-Tu (57 lM, Fmax 87) and Ss(GM)EF-1a (50 lM, Fmax 222). These
findings, besides indicating that eubacterial EcEF-Tu has an affinity
for tetracycline higher than archaeal SsEF-1a, confirm that the
M-domain of the elongation factor plays a role in the antibiotic bind-
ing. Finally, eubacterial domains were able to increase the affinity for
the antibiotic with respect to the archaeal domain.
Effect of tetracycline on the functional
properties of SsEF-1a
The interaction between SsEF-1a and tetracycline was also studied
in terms of the effect produced by the antibiotic on the functional
properties of the elongation factor.
We first analysed the ability of tetracycline to inhibit protein syn-
thesis using a reconstituted system containing purified macromolec-
ular components from S. solfataricus. The effect of tetracycline on
the kinetics of [3H]Phe polymerisation at 75 C, reported in Fig-
ure 3A, indicated that at 2 mM antibiotic, a reduction of threefold
of the rate was observed. The effect of different concentration of
tetracycline on poly(Phe) incorporation is reported in Figure 3B. The
concentration of antibiotic leading to 50% inhibition was derived
from a first-order analysis of the data (Figure 3C). The value
obtained (1.1 mM) was identical to that measured using a cell-free
reconstituted system (37), even though it was at least one order of
magnitude higher than that required for the eubacterial process.
To identify the partial reaction catalysed by SsEF-1a possibly
affected by this antibiotic, we tested the ability of SsEF-1a to
A B C D E
Figure 1: Effect of tetracycline on the fluorescence spectra of elongation factor 1a from Sulfolobus solfataricus (SsEF-1a), Escherichia coli
EF-Tu (EcEF-Tu) and the engineered forms of the archaeal elongation factor. Spectra were recorded as described in Materials and Methods, at
25 C in the absence (continuous line) or in the presence (dashed line) of 16 lM tetracycline using 4.5 lM of each protein. (A) SsEF-1a, (B)
Ss(GM)EF-1a, (C) Ss(G)EF-1a, (D) EcEF-Tu, (E) archaeal ⁄ eubacterial chimaeric elongation factor.
A B
Figure 2: Effect of tetracycline on the fluorescence intensity of
elongation factor 1a from Sulfolobus solfataricus (SsEF-1a), Escheri-
chia coli EF-Tu (EcEF-Tu) and the engineered forms of the archaeal
elongation factor. (A) The increase in the fluorescence intensity
upon excitation at 280 nm caused by tetracycline was measured at
314 nm for SsEF-1a ( ), 310 nm for Ss(GM)EF-1a (s), 314 nm for
Ss(G)EF-1a (•), 310 nm for EcEF-Tu (h) or 330 nm for the archa-
eal ⁄ eubacterial chimaeric elongation factor ( ). The concentration
of each protein was 4.5 lM. (B) The data reported in (A) were trea-
ted as a double reciprocal plot, except that referred to Ss(G)EF-1a.
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interact with aa-tRNA in the absence or in the presence of tetracy-
cline. As shown in Figure 4, the amount of ternary complex formed
between heterologous Val–EctRNAVal, SsEF-1a and nucleotides was
almost identical either in the absence or in the presence of tetracy-
cline, as revealed by the ability of the elongation factor to protect
[3H]Val–EctRNAVal against spontaneous deacylation. In addition, the
antibiotic did not affect the affinity for the nucleotide in ternary com-
plex formation, still remaining lower for GDP (Figure 4B) with respect
to that for GppNHp (Figure 4A), a slowly hydrolysable GTP analogue.
Effect of tetracycline on the interaction
between SsEF-1a and guanosine nucleotides
The effect of tetracycline on guanosine nucleotide exchange ability
of SsEF-1a was also studied. As shown in Figure 4, the presence of
tetracycline caused a 2.1-fold faster [3H]GDP ⁄GTP exchange rate on
SsEF-1a (Figure 5A), whereas in the case of [3H]GDP ⁄GDP
exchange, both rates resulted undistinguishable from each other
(Figure 5B). The effect of the antibiotic on the GDP binding was
also evaluated in terms of the equilibrium dissociation constant of
the binary complex formed with the elongation factor. The data
reported in Table 1 indicated that tetracycline slightly reduces the
affinity for both GDP and GTP, and in the case of the nucleotide
diphosphate, the reduced affinity measured in the presence of the
antibiotic can be ascribed to a selective reduction in the association
rate constant.
To better evaluate the effect of the antibiotic on the interaction
between SsEF-1a and guanosine nucleotides, we have checked
whether tetracycline affected the intrinsic GTPase of the elongation
factor and its truncated forms triggered by high concentration of
NaCl (39,46). The results shown in Figure 5 indicate that tetracycline
inhibited the GTPaseNa of SsEF-1a but not that elicited by its engi-
neered forms. The inhibition level observed for SsEF-1a depended on
the antibiotic concentration (Figure 6A), even though a complete inhi-
bition was not reached even in the presence of 120 lM antibiotic, a
concentration corresponding to about 200-fold molar excess over the
elongation factor. However, the concentration of tetracycline for half
inhibition of SsEF-1a GTPase can be calculated as about 322 lM
(Figure 6B). The effect of the antibiotic on the kinetic parameters of
the reaction (Table 2) indicated that tetracycline exerted a mixed
inhibition; in fact, besides a reduced maximum hydrolytic rate, also a
slight reduced affinity for the nucleotide was observed.
Effect of tetracycline on the heat stability of
SsEF-1a
The interaction between tetracycline and SsEF-1a was also studied
through the effect exerted by the antibiotic on the heat inactivation
kinetics of the GTPaseNa catalysed by SsEF-1a in the interval 87–
96 C. As shown in Figure 7A, the antibiotic did not affect the
first-order behaviour of the heat inactivation kinetic at all the tem-
perature investigated. The analysis according to the Arrhenius
A B C
Figure 3: Effect of tetracycline on the poly(U)-directed poly(Phe) synthesis catalysed by elongation factor 1a from Sulfolobus solfataricus
(SsEF-1a). (A) 250 lL of the reaction mixture contained 25 mM Tris•HCl pH 7.5, 19 mM magnesium acetate, 10 mM NH4Cl, 10 mM dithiothrei-
tol, 2.4 mM ATP, 1.6 mM GTP, 0.16 mg ⁄mL poly(U), 3 mM spermine, 0.25 lM Ssribosome, 80 lg ⁄mL SstRNA, 0.1 lM SsEF–2, 2.0 lM [3H]Phe
(specific activity 1268 cpm ⁄ pmol). The reaction was started by addition of 0.5 lM final concentration of SsEF-1a in the absence (s) or pres-
ence (•) of 2 mM tetracycline and carried out at 75 C. At the times indicated, 50-lL aliquots were withdrawn, chilled on ice and then anal-
ysed for the amount of [3H]Phe incorporated. (B) Effect of different concentrations of tetracycline. At each antibiotic concentration, the assay
was carried out as reported in (A). (C) The data reported in (B) were treated as a first-order behaviour. A0 represents the activity measured in
the absence of tetracycline, whereas AC is the activity at the concentration C of tetracycline.
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equation of the kinetic constants of the heat inactivation process
(Figure 7B) allowed the calculation of the energetic parameters of
the activation. The data reported in Table 3 indicated that tetracy-
cline increased the rate of the heat inactivation through a reduction
in the energy of activation without affecting the free energy associ-
ated with the process.
Discussion
Tetracycline, a broad-spectrum antibiotic produced by the Strepto-
myces genus of Actinobacteria, is a protein synthesis inhibitor act-
ing on 30S ribosome subunit of eubacteria (47). More recently, a
direct interaction between this antibiotic and the EF-Tu from E. coli
was reported by crystallographic studies pointing to a different
mode of action of tetracycline (14). Because different eubacterial
antibiotics, like kirromycin (32,33), GE2270A (35) and fusidic acid,
(36) interact with the homologous archaeal elongation factors from
S. solfataricus, a study on the interaction between tetracycline and
SsEF-1a was undertaken. The availability of three engineered forms
of the archaeal elongation factor (39,41) allowed a dissection of
the molecular requirements involved in the interaction.
The interaction between SsEF-1a and tetracycline was demonstrated
either by fluorescence spectroscopy in the aromatic region of the
spectrum or by the effects produced by the antibiotic on some func-
tional properties of the elongation factor; in particular, spectroscopic
data showed in the presence of the antibiotic an increase in the
quantum yield in the fluorescence spectrum of SsEF-1a. A similar
behaviour was also observed for EcEF-Tu, Ss(GM)EF-1a and the chi-
maeric elongation factor containing the nucleotide-binding domain of
SsEF-1a and the other two domains of EcEF-Tu, but not for Ss(G)EF-
1a. These results indicated that the M-domain of archaeal ⁄ eubacte-
rial factor is essential for the interaction with tetracycline. However,
the value of the tetracycline concentration to reach half the maxi-
mum fluorescence for SsEF-1a was higher than that found for the
chimeara, EcEF-Tu and Ss(GM)EF-1a in the order, thus indicating that
A B
Figure 4: Effect of the tetracycline on the formation of the ter-
nary complex between elongation factor 1a from Sulfolobus solfa-
taricus (SsEF-1a), [3H]ValEc–tRNAVal and GDP or GppNHp. The
mixture (30 lL) contained 25 mM Tris•HCl, pH 7.8, 10 mM NH4Cl,
10 mM DTT, 20 mM magnesium acetate and 4.6 pmol of [3H]ValEc–
tRNAVal (specific radioactivity 1521 cpm ⁄ pmol) and was incubated
for 1 h at 0 C to allow ternary complex formation in the presence
of the indicated amount of SsEF-1aÆGppNHp (A) or SsEF-1aÆGDP (B),
in the absence (s) or in the presence (•) of 50 lM tetracycline.
The deacylation reaction was carried out for 1 h at 50 C, and the
residual [3H]ValEc–tRNAVal was determined as cold trichloroacetic
acid insoluble material.
A B
Figure 5: Effect of tetracycline on the nucleotide exchange rate
catalysed by elongation factor 1a from Sulfolobus solfataricus
(SsEF-1a). The reaction mixture (300 lL) prepared in buffer A con-
tained 0.5 lM SsEF-1aÆ[3H]GDP in the absence (s) or in the pres-
ence (•) of 50 lM tetracycline. The nucleotide exchange reaction
was started at 60 C by adding 1 mM GDP (A) or GTP (B) final con-
centration. At the times indicated, the amount of the residual radio-
labelled binary complex was determined on 30-lL aliquots by
nitrocellulose filtration. The data were treated according to a first-
order kinetic.
Table 1: Effect of tetracycline on the affinity of SsEF-1a for gua-
nosine nucleotides at 60 C
SsEF-1a
Kd' k)1 k+1
GDP (lM) GTP (lM)
GDP (1 ⁄
min)
GDP (1 ⁄
lM•min)
) Tetracycline 0.3 € 0.08 6.0 € 1.3 0.13 € 0.03 0.43
+ Tetracycline 0.5 € 0.1 9.0 € 2.0 0.12 € 0.04 0.24
SsEF-1a, elongation factor 1a from Sulfolobus solfataricus.
The Kd' and k)1 values represent the average of 3–4 different determina-
tions.
k+1 was calculated as k)1 ⁄ Kd'.
Lamberti et al.
264 Chem Biol Drug Des 2011; 78: 260–268
the eubacterial elongation factor has an higher affinity for the antibi-
otic with respect to the archaeal one.
Regarding the effects on the functional properties of the enzyme,
tetracycline, although at concentration at least one order of magni-
tude higher than that required for the eubacterial process, was able
to inhibit protein synthesis. In addition, the antibiotic slightly
reduced the affinity of SsEF-1a for guanosine nucleotides. In the
case of GDP, the increased equilibrium dissociation constant of the
binary complex SsEF-1a•GDP can be ascribed to a greater decrease
in the association rate constant than the dissociation one. In the
case of the GDP ⁄GTP exchange reaction on the archaeal elongation
factor, tetracycline has a more pronounced effect, making the rate
faster and more similar to GDP ⁄GDP.
The effects of the antibiotic on the intrinsic GTPase catalysed by
SsEF-1a in the presence of NaCl appeared limited and undetectable
on the truncated forms of the factor. This behaviour, in contrast to
the data reported on the spectroscopic properties, can be attributed
to the high concentration of NaCl (3.6 M) needed to induce the
GTPase activity of both intact (46) and engineered forms of the
elongation factor (39,41). However, the concentration of antibiotic
needed to get a 50% inhibition of the intrinsic GTPase of SsEF-1a
(322 lM) is very similar to that derived from fluorescence titration
and of the same order of magnitude than that required to inhibit to
50% the protein synthesis in vitro in some micropathogens (400–
850 lM) but also in a cell-free reconstituted system of S. solfatari-
cus and S. acidocaldarius (37,48).
The interaction between SsEF-1a and tetracycline caused a reduction
of the heat inactivation of the archaeal elongation factor, as demon-
strated by a lower value of the energy of activation of the process.
The analysis of the thermodynamic parameters of the heat inactiva-
tion process at 87 C (Table 3) indicated that the antibiotic reduced
both the enthalpy and the entropy of activation without affecting the
Table 2: Effect of tetracycline on the kinetic parameters of the
GTPaseNa catalysed by SsEF-1a at 60 C
Km (lM) kcat (1 ⁄ s)
kcat ⁄ Km
(1 ⁄ sÆlM)
) Tetracycline 2.5 € 0.8 0.50 € 0.12 0.20
+ Tetracycline 4.5 € 1.3 0.36 € 0.14 0.08
SsEF-1a, elongation factor 1a from Sulfolobus solfataricus.
The Km and kcat values represent the average of 3–4 different determina-
tions.
A B
Figure 7: Effect of tetracycline on the heat inactivation of the
GTPaseNa of elongation factor 1a from Sulfolobus solfataricus
(SsEF-1a). (A) 4 lM SsEF-1a was incubated at 87 (s), 90 (•), 93
(h) or 96 C ( ) in the presence of 16 lM tetracycline, and at the
indicated time intervals, aliquots were withdrawn and placed at
0 C. The residual GTPase activity was determined as reported in
Materials and Methods and referred to an untreated sample kept
at 0 C for all the experiment of the heat treatment. The data were
treated as a first-order kinetic and reported as the natural logarithm
of the residual activity. (B) Arrhenius analysis of the heat inactiva-
tion kinetic rate constants (kin) derived from the slope of the equa-
tions reported in (A).
Table 3: Effect of tetracycline on the energetic parameters of
activation of the inactivation process
Ea
(kJ ⁄mol)
DH*
(kJ ⁄mol)
DS*
(J ⁄mol•K)
DG*
(kJ ⁄mol)
) Tetracycline 361 358 665 119
+ Tetracycline 177 174 164 115
DH*, DS* and DG* were calculated at 87 C.
A B
Figure 6: Effect of tetracycline on the intrinsic GTPase of SsEF-
1a and its engineered forms. (A) The GTPaseNa activity of SsEF-1a
( ), Ss(GM)EF-1a (s), Ss(G)EF-1a (•) and the archaeal ⁄ eubacterial
chimaeric elongation factor ( ) was determined in the presence of
the indicated tetracycline concentration, as described in Materials
and Methods. The data were referred to the value measured in the
absence of the antibiotic. (B) The data referring to SsEF-1a were
linearised using a first-order behaviour equation.
Antibiotic Tetracycline and Archaeal EF–1a
Chem Biol Drug Des 2011; 78: 260–268 265
free energy associated with the process. This finding can be
explained by a less favourable entropic factor induced by tetracycline
in the attainment of the activation state of the inactivation process.
The interaction between SsEF-1a and tetracycline was also anal-
ysed in terms of amino acid residues of the elongation factor
involved, through the alignment between the primary structures
of EcEF-Tu and SsEF-1a (Figure 8). Among the residues identified
in the catalytic domain of EcEF-Tu involved in the binding of the
antibiotic (14), those of the consensus sequences of guanosine
nucleotide-binding proteins (Asp21, Thr25, Asp80, and Pro82, EcEF-Tu
numbering) as expected are conserved in SsEF-1a. Regarding the
other residues involved in the interaction with the antibiotic and
belonging to this domain (Thr64, Ser65, Val67 and Leu178, EcEF-
Tu numbering), although a Ser65 fi Thr and a Val67 fi Met
were found as conservative substitutions, the other two residues
were not conserved in SsEF-1a (Thr65 fi Leu and Leu178 fi
Asp, EcEF-Tu numbering, respectively). Concerning the amino acid
residues involved in the dimer formation through protein–protein
interaction, those participating in the stabilisation of the con-
served flexible region Ile220 fi Arg223 were also present in
SsEF-1a; vice versa, differences were found in the residues
belonging to the Arg262 fi Leu264 loop, even though some of
the residues involved in its stabilisation were conserved (Asp216
and Glu259).
Conclusions
In conclusion, the data presented demonstrate the interaction
between an archaeal elongation factor 1a and the eubacterial anti-
biotic tetracycline. These results, besides being useful for studying
the interaction between tetracycline and eukaryotic elongation fac-
tors and hence for the assessment of potential side effects, could
provide a basis for the development of new drugs whose mecha-
nism of action is based on the interaction between specific amino
acid residues of target proteins and reactive portions in the struc-
ture of this family of antibiotics.
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